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Caffeinated and fructose-rich beverages are widely consumed among women of 
reproductive age but their association with reproductive hormones is not well understood, 
due in part to inadequate exposure assessment. Our objectives were to 1) assess the 
relationship between caffeine and fructose intake and reproductive hormones in healthy 
premenopausal women, evaluating potential effect modification by race; and 2) 
determine the validity of the Food Frequency Questionnaire (FFQ) for measuring 
monthly caffeinated beverage intake compared to multiple 24-hour dietary recalls 
(24HDR). The BioCycle Study (2005-2007) prospective cohort (n=259) included women, 
ages 18-44, who were followed for 2  menstrual cycles, providing fasting blood 
specimens at up to 8 visits per cycle, 4 24HDRs per cycle, and an FFQ at the end of each 
cycle.  
Caffeine intake ≥200 mg/day was inversely associated with free estradiol (E2) 
concentrations among white women (β=-0.15 [95% confidence interval (CI): -0.26, -
0.05] and positively associated among Asian women (β=0.61 [95% CI: 0.31, 0.92] after 
taking into account potential confounders. Women who consumed more added sugar than 
an average American woman (≥ 73.2 grams/day) or above the 66th percentile in fructose 
intake (≥ 41.5 grams/day) had elevated free E2 concentrations compared to women who 
consumed less. Women who consumed ≥1 cup/day of sweetened soda had elevated free 
E2 (β=0.15 [95% CI: 0.06, 0.24]. Neither artificially sweetened soda intake nor fruit juice
iv 
 
intake ≥1 cup/day was significantly associated with reproductive hormones. Caffeine 
intake reported in the FFQ was greater than that reported in the 24HDRs (mean=114.1 
versus 92.6 mg/day; P=0.006) despite high correlation (r=0.80, P<0.001) and moderate 
agreement (kappa=0.56, 95% CI: 0.42-0.70).  
In summary, moderate caffeine consumption was associated with reduced E2 
among white women and elevated E2 among Asian women. Added sugars, total fructose, 
and sweetened soda were associated with elevated E2 among all races. Further research 
on the association between caffeine, caffeinated beverage components and reproductive 
hormones, and whether these relationships differ by race, is warranted. Additionally, 
although caffeine exposures are highly correlated, absolute intakes differ significantly 
between measurement tools, highlighting the importance of considering potential 
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Caffeine intake by women of childbearing age is common in the United States 
(US). Approximately 89% of reproductive-age women consume caffeine daily, averaging 
166 mg/day. This equates roughly to 1.5 to 2 cups of caffeinated coffee depending on the 
roast and brewing method (1, 2). Only limited research has been conducted on the effect 
of caffeinated beverages on reproductive hormone levels (3-6) and ovulatory function (7-
9) among premenopausal women, and the results have been inconclusive (3-9). 
Inconsistent results are likely due to methodological limitations, specifically inadequate 
hormone assessment using standard methods to time a woman’s cycle phase; failure to 
use a validated and reliable caffeine exposure tool; inadequate control for confounding 
variables; and retrospective study designs that are prone to recall bias. Furthermore, 
previous studies that have set out to investigate the effect of caffeine on female 
reproductive hormones and ovulatory function have found effects to differ based on 
beverage type, indicating that other or additional compounds in beverages besides 
caffeine may also play a role (3, 4, 6, 9). Abnormal levels of reproductive hormones 
during the premenopausal years may not only affect ovulatory function in the short term 
(9), but may also affect the etiology of certain diseases, such as breast cancer, in the long 




Development of guidelines regarding appropriate consumption of caffeinated beverages 
for premenopausal women (10). 
Mechanisms of Effect on Reproductive Hormones  
and Ovulatory Function 
A variety of pathophysiological effects of caffeine and components of caffeinated 
beverages on reproductive hormones and ovulatory function have been proposed. 
Caffeine may enhance steroid production via inhibition of the enzyme phosphodiesterase 
(4, 11) or alternatively may interfere with estrogen metabolism via inhibition of 
aromatase, a member of the cytochrome P450 (CYP) superfamily (6, 13). Caffeine may 
have a protective effect on ovulatory function by lowering leptin levels (12) and 
improving (i.e., elevating) insulin sensitivity (4, 13, 14). Alternatively, caffeine may 
interfere with oocyte maturation and thus adversely affect ovulatory function via the 
phosphodiesterase inhibiting mechanism. Regarding caffeinated beverages, coffee and tea 
are known to contain antioxidants that may adversely affect ovulation (15) as might 
certain other components in sodas (9, 11).  
 Both genetic and environmental factors play a role in caffeine metabolism and 
evidence has shown that caffeine and caffeine metabolites (including paraxanthine, 
theophylline, and theobromine) have differing effects on health outcomes (16). 
Genotypes for cytochrome P-450 1A2 (CYP1A2), the enzyme responsible for caffeine 
metabolism, vary across ethnic groups, with Asian and African populations appearing to 
metabolize caffeine more slowly than Caucasians (17, 18). Additionally, the rate of 
caffeine absorption is slowed by the presence of food in the stomach and the use of oral 




Effects of Caffeine and Caffeinated Beverages 
on Female Hormones 
Caffeine and Coffee  
Since coffee is the largest contributor to caffeine exposure (e.g., 1 cup of coffee 
has approximately 100 mg of caffeine compared to a cup of tea or soda, which has half to 
a quarter the caffeine content), most studies find similar results for the effects of caffeine 
and caffeinated coffee on health outcomes.  Research thus far regarding caffeine and 
coffee intake and female reproductive hormones and ovulatory function is limited and 
conflicting. Kotsopoulos et al. examined free estradiol (E2) plasma concentrations in 524 
predominately white (20) premenopausal women from the Nurses’ Health Study (NHS) 
and follow-up NHSII and found an inverse association in trend analyses for both caffeine 
and coffee intake and geometric mean levels of luteal (but not follicular) free E2 (6). 
Similarly, London et al. found an inverse relationship with caffeine and follicular percent 
free E2 among 325 healthy, premenopausal women (race not specified) from the 
Massachusetts Women’s Health Study (21). In contrast to the above studies, Lucero et al. 
found coffee and caffeine intake associated in trend analyses with increasing geometric 
mean levels of early follicular phase total E2 concentrations in a study of 498 
predominately (97%) white women ages 36 to 45 (4) while Kinney et al. found no 
association between caffeine and early follicular phase total E2 concentrations in a study 
of 188 predominately (95%) white women (mean age=34.0) (5). A study among a small 
sample (n=50) of Japanese college women found adjusted total caffeine and coffee to be 
highly correlated to Sex Hormone Binding Globulin (SHBG) concentrations, a 





The effects of major types of tea on reproductive hormones have also received 
limited investigation. One study, which was restricted to Asian women, differentiated 
exposure by tea type (black, oolong, and green) and found green tea to be inversely 
correlated with follicular estradiol (3). Animal research supports increased estradiol 
concentrations for intake of green tea (22). Further research with regard to the effects of 
black versus green tea on reproductive hormones is justified since previous research has 
shown differing effects on reproductive cancers (23). 
Soda 
Only 1 study has investigated soda and premenopausal reproductive hormone 
levels finding no effect, but restricted their investigation to cola and as explained above, 
had a small sample size (n=50) and limited exposure/outcome assessment (3).  While 
limited data exist on the effect of soda on reproductive hormones, studies have 
demonstrated that sodas are associated with impaired fasting glucose and metabolic 
syndrome (24, 25). Among normal-weight women, increased consumption of fructose-
sweetened beverages has been shown to lower circulating concentrations of glucose, 
insulin and leptin and increase postprandial triacylglycerol concentration (26), all of 
which influence the feedback mechanisms of reproductive hormones (27, 28).  
Effects of Caffeine and Caffeinated Beverages  
on Ovulatory Function 
Only 3 previous studies have investigated the effect of caffeine and/or caffeinated 




ovulatory function has been found (7-9); soda consumption, however, has been shown to 
be a risk factor for ovulatory disorder infertility (RR: 1.47, P for trend 0.01) based on 
data from the NHSII (9). In support of this finding, a previous study looking at effects of 
caffeinated beverages on fecundability found intake of 1 8-oz serving of caffeinated soda 
was associated with a 50% reduction in the monthly probability of conception (29). Since 
soda intake has risen dramatically in the last few decades, rising from approximately 2 8-
oz servings/week in 1942 to 2 8-oz servings/day in 2000 (30), and is responsible for the 
majority of fructose  intake among women in the US, many investigators examining the 
rise of obesity, metabolic syndrome and type 2 diabetes have turned their attention to 
fructose. While some studies have found adverse health effects from sweetened soda 
intake (31), other studies have found effects with all types of sodas (irrespective of 
caffeine or sugar content).  This may indicate that there is some other factor associated 
with sodas besides caffeine or fructose that is responsible for the observed effects (9, 32). 
Adding to the complexity, studies in rats have shown that estrogen protects against the 
development of hyperinsulinemia associated with high fructose intake, explaining why 
gout is more prevalent in men than in reproductive-aged women (33). Whether it is 
dietary fructose in sodas or some other component that may affect reproductive hormone 
levels and ovulatory function in premenopausal women and by what mechanism needs to 
be elucidated via further research. 
Purpose of the Study 
The main objectives of this study are: 1) to determine prospectively if caffeine or 
caffeinated beverages and 2) fructose and fructose-rich beverages are related to serum 




healthy, premenopausal women using a standardized method to time serum sample 
collections. We also wished to assess the validity and reproducibility of the Food 
Frequency Questionnaire for measuring caffeine and caffeinated beverage compared to 
repeated 24-hour dietary recalls. 
The overall goals for this study are to both improve the methodology in assessing 
the effect of caffeine and caffeine related beverage intake on health outcomes for 
premenopausal women and to add to the body of research that seeks to concur on a safe 
threshold of caffeine and caffeine related beverage intake for women of premenopausal 
age. 
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CAFFEINATED BEVERAGE INTAKE AND REPRODUCTIVE 
HORMONES AMONG PREMENOPAUSAL WOMEN  
IN THE BIOCYCLE STUDY 
Abstract 
Caffeinated beverages are widely consumed among women of reproductive age 
but their association with reproductive hormones, and whether race modifies any such 
associations, is not well understood. We assessed the relationship between caffeine and 
caffeinated beverage intake and reproductive hormones in healthy premenopausal 
women, evaluating potential effect modification by race. Participants (n=259) were 
followed for up to 2 menstrual cycles, providing fasting blood specimens for hormonal 
assessment at up to 8 visits per cycle and 4 24-hour dietary recalls per cycle. Weighted 
linear mixed models and nonlinear mixed models with harmonic terms were used to 
estimate associations between caffeine and hormone concentrations, adjusting for age, 
adiposity, physical activity, energy and alcohol intake, and perceived stress. Based on a 
priori assumptions, an interaction between race and caffeine was tested, and stratified 
results are presented. Caffeine intake ≥200 mg/day was inversely associated with free 
estradiol concentrations among white women (β=-0.15 [95% confidence interval (CI): -




CI: 0.31, 0.92]. Caffeinated soda and green tea intake ≥1 cup/day was positively 
associated with free estradiol concentrations (β=0.14 [95% CI: 0.06, 0.22] and β=0.26 
[95% CI: 0.07, 0.45]) among all races. Moderate consumption of caffeine was associated 
with reduced estradiol concentrations among white women, while caffeinated soda and 
green tea intake were associated with increased estradiol concentrations among all races. 
Further research on the association between caffeine and caffeinated beverages and 
reproductive hormones, and whether these relationships differ by race, is warranted. 
Introduction 
Caffeine intake by women of childbearing age is common in the US. 
Approximately 89% of women aged 18-34 consume on average 166 mg/day of caffeine 
(equivalent to 1.5 to 2 cups of caffeinated coffee) from a variety of sources but mostly 
from caffeinated beverages (1, 2). Despite the prevalence of intake, research relating 
caffeine and reproductive hormone concentrations among premenopausal women is 
limited and inconclusive (3-6). Inconsistent results may partially be due to the fact that 
endocrine dynamics of female reproductive hormones (7, 8) and caffeine metabolism (9, 
10) are known to have interethnic variability. The association between caffeine and 
hormones is of interest, as persistent elevation or insufficiency of reproductive hormones 
during the premenopausal years may not only contribute in the long term to the etiology 
of certain diseases such as breast, endometrial, and ovarian cancer (11-13) but may also 
in the short term affect ovulatory function (15)(16). Further understanding of these 
associations can inform the development of appropriate guidelines regarding 




A variety of pathophysiological effects of caffeine and components of caffeinated 
beverages on sex hormones and ovulatory function exist. Animal models suggest that 
caffeine can inhibit oocyte maturation or enhance steroid production via inhibition of 
phosphodiesterase (4, 18) or alternatively, may interfere with estrogen metabolism via 
inhibition of aromatase, the key enzyme responsible for converting androgens to estrogen 
(6, 19). Studies in women have suggested that caffeine may have a positive (4), inverse 
(6), or null association with estradiol (E2) (5) but has no effect on ovulatory function (16, 
20, 21), although no studies to date have prospectively measured caffeine intake at 
multiple time points and directly measured ovulation. Both caffeine and E2 are 
metabolized by the hepatic enzyme P450 1A2 (CYP1A2) (22, 23). Polymorphisms of 
CYP1A2 have been linked to variability in caffeine clearance (24) and serum E2 
concentrations (25), and have been shown to modify relationships between caffeine 
intake and adverse health outcomes (26, 27). Estrogen and caffeine metabolism and risk 
of breast and ovarian cancer have also been shown to differ between whites and Asians 
(28-30). It is unknown whether differences in caffeine consumption and metabolism 
could partially explain these differences.  
The primary objective of this study is to determine whether caffeine and its 
associated beverages (coffee, tea, and soda) are related to serum concentrations of 
reproductive hormones in a cohort of 259 healthy, premenopausal women, and whether 
these associations differ by race. Our secondary objective is to determine whether 






Subjects and Methods 
Study Population 
The BioCycle Study, conducted in 2005-2007, followed women from western 
New York State for 1 (n=9) or 2 (n=250) complete menstrual cycles. The study 
population, materials and methods have been previously described in detail (31). In 
summary, healthy women aged 18-44 had to be regularly menstruating (self-reported 
cycle length between 21 and 35 days for each menstrual cycle in the past 6 months) and 
not currently using hormonal contraception (and for the 3 months prior to study entry) to 
participate. Of 449 women who were screened, 318 met the eligibility criteria, of whom 
276 enrolled. Seventeen women (6%) withdrew before completing the study (31). 
Women reporting conditions known to affect menstrual cycle function such as polycystic 
ovary syndrome, uterine fibroids, or known ovulatory disorders were excluded. The 
University at Buffalo Health Sciences Institutional Review Board (IRB) approved the 
study and served as the IRB designated by the National Institutes of Health for this study 
under a reliance agreement. A written informed consent was obtained from all 
participants. 
Hormone Assessment 
Women provided fasting blood specimens on up to 8 visits per cycle, with visit 
timing assisted by use of fertility monitors to correspond to menstruation, mid-follicular, 
late follicular, luteinizing hormone (LH)/follicle-stimulating hormone (FSH) surge, 
ovulation, early luteal, mid-luteal, and late luteal phases (32). Total E2 was measured via 
radio immunoassay while progesterone, LH, FSH, sex hormone binding globulin 




enzyme immunoassay (Immulite 2000). Albumin assay was tested on the Beckman LX20 
auto analyzer using bromcresol purple methodology. Calculation of free E2 (i.e., 
bioavailable E2) was performed via the equation proposed by Sodergard et al. using total 
E2, SHBG and albumin concentrations (33). All hormonal analyses were conducted by 
Kaleida Health Laboratories in Buffalo, New York.  Across the study period, the 
coefficient of variation (CV) for these tests was <10% for E2, SHBG, and insulin, <5% 
for LH, FSH, and albumin, and <14% for progesterone. Insulin resistance was calculated 
using the homeostasis model assessment (34). Total cholesterol was measured in serum at 
each clinic visit using an LX20 automated chemistry analyzer (Beckman, Brea, CA), with 
a CV of <5%. We defined anovulation as any cycle with peak progesterone concentration 
≤ 5 ng/mL and no observed serum LH peak on the mid- or late-luteal phase visits (n=42 
of 509 cycles (8.3%)). Study protocol compliance was high, with 94% of the participants 
completing 7 or 8 visits per cycle. 
Dietary Assessment 
Participants completed a 24-hour dietary recall (24HDR) at the clinic during the 4 
visits corresponding to menstruation, mid-follicular phase, ovulation, and mid-luteal 
phase. Food and beverage intake was collected and nutrient data were analyzed using the 
Nutrition Data System for Research (NDSR, 2005, Nutrition Coordinating Center, 
University of Minnesota, Minneapolis, MN). The NDSR program computed the nutrients 
(i.e., total energy) and non-nutrients (i.e., caffeine) along with beverage components (i.e., 
coffee) consumed for each day of intake.  Further abstraction was done from the raw 
24HDR data to discriminate between caffeinated, decaffeinated, or noncaffeinated 




standard NDSR output. Eighty-seven percent of the participants completed 4 dietary 
recalls per cycle; 99% completed 3. 
Covariate Assessment 
At study enrollment, waist-to-hip ratio was obtained using standardized protocols 
by trained study staff, while age, self-identified race, smoking, alcohol intake, 
reproductive history, and perceived stress were obtained using validated questionnaires 
(31). For prospectively measured covariates, participants were provided a diary where 
they were instructed to record daily vigorous exercise (minutes), cigarettes smoked 
(number), sexual intercourse (yes/no), sleep (hours and minutes), and medication intake 
(type, dose, units, and number of times per day). Caffeine from medications (primarily 
from over-the-counter preparations with nonsteroidal anti-inflammatory drugs) was 
averaged for each phase over the 2 cycles and added to the caffeine calculated from the 8 
24HDRs. Eighty-nine percent of participants completed at least 75% of their daily 
diaries. 
Statistical Analyses  
Descriptive characteristics of the study population were compared between 
tertiles of daily caffeine intake, averaged over the 2 cycles under study, and anovulatory 
status. We assessed differences using analysis of variance per the Satterthwaite method 
for unequal variances and exact chi-square tests where appropriate (35). Reproductive 
hormones and serum cholesterol concentrations were log transformed for statistical 
analyses. Percent of women consuming caffeinated and/or decaffeinated/noncaffeinated 




addition to caffeine source, based on total caffeinated food, beverage, or medication 
items reported. 
Weighted linear mixed models were used to evaluate the association between 
visit-specific caffeine, coffee, tea, or soda intake and log serum concentrations of free and 
total E2, luteal progesterone, LH, and FSH. Generalized linear mixed models were used 
to estimate the odds of anovulation based on caffeine and caffeinated beverage 
consumption. These random-intercept models were chosen to account for between-
women variation in baseline hormone concentrations and within-woman correlations of 
cycles. Recommended limits of caffeine for reproductive-aged women, ≥200mg/day 
versus <200mg/day (including no exposure) (36); and relevant cut-points for coffee, tea, 
or soda intake, ≥ 1 cup/day versus < 1cup/day (including no exposure) (4) were assessed. 
Models were restricted to ovulatory cycles (n=467), as the hormonal patterns for 
anovulatory cycles are distinctly different from ovulatory cycles. 
Based on previous evidence for potential biologic effect modification (4, 37), we 
tested for interactions between caffeine or beverage exposure and both race and dietary 
cholesterol intake using the likelihood ratio test (α=0.10). Lucero et al. reported that 
women whose cholesterol consumption was > 217 mg/day had higher E2 concentrations 
compared with women whose cholesterol intake was ≤ 217 mg/day (4). Thus, we tested 
whether there was an interaction between caffeine and cholesterol intake at this cut point 
(near our participants’ average intake of 214 mg/day). In addition to race and dietary 
cholesterol, we also separately evaluated effect modification by age and waist-to-hip 
ratio. Stratified analyses (using models with relevant interaction terms) are presented 




a priori using directed acyclic graphs (DAGs) (38).  Age, race, waist-to-hip ratio, daily 
exercise, perceived stress, total energy and alcohol intake (all continuous) were included 
in our final models. Additional covariates including other caffeinated beverage intake 
(i.e., adjusting for caffeinated soda and tea when investigating coffee), cigarette use, 
reproductive history (i.e., gravidity and past oral contraceptive use), sleep, sexual 
activity, dietary intake (i.e., fiber; cholesterol; and percent calories from carbohydrate, fat 
and protein), serum cholesterol, and insulin resistance were considered but did not 
appreciably alter the estimates (39). Based on our proposed DAG, the minimum set of 
confounders we adjusted for takes into account all sources of measured and known 
confounding. Since E2 concentrations change over the cycle in response to complex 
feedback mechanisms with other hormones, traditional regression adjustment for LH, 
FSH, and progesterone is inadequate. Therefore, we present models that additionally 
adjust for other reproductive hormones (e.g., progesterone, FSH, LH) through stabilized 
inverse probability of exposure weights (40, 41).  
To assess how caffeine and caffeinated beverage intake affect hormonal patterns, 
we applied nonlinear mixed models with harmonic terms. While the linear mixed models 
allow for estimation of mean differences, these harmonic models can additionally 
evaluate differences in amplitude (i.e., difference between nadir and peak concentrations) 
and timing of phase shifts while taking into account between and/or within subject 
variation (42).  
Sensitivity analyses were conducted to assess the effects of continuous and 
varying cut points of caffeine (tertiles and 100 mg increments) or caffeinated beverage (1 




hormones, we assessed effects of including anovulatory cycles or excluding smokers. For 
anovulation, we assessed the effects of caffeine and caffeinated beverages on the less 
conservatively defined anovulation (i.e., cycles with progesterone concentrations ≤ 5 
ng/mL) or when excluding smokers.  Analyses were performed in SAS version 9.2 (SAS 
Institute, Cary, NC). 
Results 
Caffeine and Beverage Consumption 
Mean caffeine intake across both cycles was 90.9 mg/day (range: 0.0 to 475.4 
mg/day). Caffeine intake was positively associated with age; white race; cigarette use; 
energy, alcohol, and fiber intake; serum FSH; and serum cholesterol concentrations and 
inversely associated with nulligravidity, perceived stress, and insulin resistance. 
Anovulation was inversely associated with age, sleep, alcohol, and caffeine intake, total 
and free E2, and luteal progesterone and positively associated with nulligravidity (Table 
2.1). 
 Over 2 cycles, 49% consumed coffee (88% exclusively caffeinated, 1% 
exclusively decaffeinated, and 11% caffeinated and decaffeinated), 60% consumed tea 
(87% exclusively caffeinated, 3% exclusively decaffeinated, and 10% caffeinated and 
decaffeinated), and 70% consumed soda (18% exclusively caffeinated, 20% exclusively 
noncaffeinated, and 62% caffeinated and noncaffeinated) (Figure 2.1). Few women 
consumed energy drinks (2%), so caffeinated energy drink consumption was combined 
with caffeinated soda consumption. Overall, 66% of caffeine intake came from coffee,
  
Table 2.1: Characteristics of women participating in the BioCycle Study by average caffeine intake and anovulatory status1  
 
  Caffeine Intake (mg/day)  Anovulatory2
 Total <25 25 – 105 > 105 P Yes No P 
Number of participants  
[n (%)] 259 86 (33.2) 84 (32.4) 89 (34.4)  35 (13.5) 224 (86.5)  
Caffeine (mg/day) 90.9 ± 94.0 10.9 ± 8.1 58.0 ± 23.7 199.4 ± 79.7 <0.001 60.2 ± 80.0 95.7 ± 95.8 0.04 
Demographic/Lifestyle         
Age (years)  27.3 ± 8.23 23.4 ± 5.8 26.5 ± 8.0 31.7 ± 8.3 <0.001 22.5 ± 5.6 28.0 ± 8.3 <0.001 
Race[n (%)] <0.001   0.27 
     White 154 (59.5) 37 (43.0) 49 (58.3) 68 (76.4) 
 
20 (57.1) 134(59.8)  
     Black 51 (19.7) 31 (36.1) 14 (16.7) 6 (6.7) 8 (22.9) 43 (19.2)  
     Asian 37 (14.3) 15 (17.4) 13 (15.5) 9 (10.1) 7 (20.0) 30 (13.4)  
     Other 17 (6.6) 3 (3.5) 8 (9.5) 6 (6.7) 0 (0.0) 17 (7.6)  
BMI (kg/m2)  24.1 ± 3.9 23.4 ± 3.6 24.6 ± 4.1 24.2 ± 3.8 0.11 23.4 ± 3.8 24.2 ± 3.9 0.25 
Waist-to-hip ratio  0.75 ± 0.06 0.75 ± 0.06 0.75 ± 0.05 0.75 ± 0.05 0.90 0.75 ± 0.05 0.75 ± 0.06 0.51 
Nulligravid [n (%)] 177 (69.4) 71 (83.5) 62 (74.7) 44 (50.6) <0.001 28 (84.9) 149 (67.1) 0.04 
Perceived Stress Score  20.2 ± 6.8 21.7 ± 74 20.3 ± 6.1 18.6 ± 6.5 0.01 20.2 ± 6.9 20.2 ± 6.8 0.99 
Cigarette Use [n (%)] 0.02   0.79 
    No 218 (84.2) 80 (93.0) 67 (79.8) 71 (79.8) 
 
30 (85.7) 188 (83.9)  
    Yes 41 (15.8) 6 (7.0) 17 (20.2) 18 (20.2) 5 (14.3) 36 (16.1)  
Sleep (hours) 7.2 ± 0.8 7.1 ± 0.9 7.2 ± 0.7 7.2 ± 0.7 0.80 6.8 ± 0.7 7.2 ± 0.8 0.01 
Daily exercise (min/day)  14.7 ± 21.9 10.9 ± 12.7 16.7 ± 27.0 16.5 ± 23.4 0.14 20.4 ± 25.2 13.9 ± 21.3 0.10 
Sex (intercourse/day)  0.09 ± 0.13 0.07 ± 0.12 0.08 ± 0.12 0.11 ± 0.14 0.10 0.05 ± 0.11 0.09 ± 0.13 0.09 
Diet     
Total energy (kcal) 1613.3 ± 367.3 1519.6 ± 342.2 1600.0± 351.5 1716.5 ± 382.6 0.002 1621.2 ± 424.7 
1612.1 ± 
358.6 0.89 
Alcohol  (grams) 2.8 ± 5.5 1.0 ± 1.9 2.3 ± 4.7 4.9 ± 7.4 <0.001 1.0 ± 2.1 3.0 ± 5.8 <0.001 19
  
Table 2.1 continued         
  Caffeine Intake (mg/day)  Anovulatory2  
 Total <25 25 – 105 > 105 P Yes No P 
Carbohydrates (% calories) 50.8 ± 7.3 51.7 ± 7.5 51.3 ± 7.3 49.4 ± 6.9 0.09 49.9 ± 8.4 50.9 ± 7.1 0.46 
Protein (% calories) 15.8 ± 3.1 16.0 ± 3.7 15.8 ± 3.0 15.7 ± 2.6 0.86 16.3 ± 3.8 15.7 ± 3.0 0.30 
Fat (% calories) 33.8 ± 5.6 33.3 ± 5.5 33.5 ± 5.7 34.6 ± 5.5 0.25 35.2 ± 5.9 33.6 ± 5.5 0.12 
Cholesterol (mg/day) 213.3 ± 106.7 196.8 ± 112.0 220.9 ± 111.6 222.1 ± 95.4 0.21 231.3 ± 128.1 
210.5 ± 
103.3 0.28 
Fiber (g/day) 13.6 ± 5.6 12.7 ± 5.5 13.2 ± 6.1 15.0 ± 4.8 0.02 15.7 ± 8.2 13.3 ± 5.0 0.11 
Reproductive Hormones         






128.8) 0.57 60.3 ± 1.4 90.0 ± 1.4 <0.001 
Free E2 (ρg/mL) 1.3 (1.1–1.6) 1.3 (1.1–1.7) 1.3 (1.1–1.5) 1.3 (1.0–1.5) 0.24 1.0 ± 0.3 1.4 ± 0.5 <0.001 
Luteal Progesterone 
(ng/mL) 3.4 (2.5–4.4) 3.3 (2.5–4.5) 3.0 (2.3–4.2) 3.7 (2.8–4.4) 0.19 0.69 ± 1.7 1.5 ± 1.5 <0.001 
LH (ng/mL) 9.2 (7.5–11.4) 9.2 (7.7–11.4) 9.1 (7.5–11.4) 9.2 (7.5–11.3) 0.59 6.7 ± 15 6.0 ± 1.4 0.27 
FSH (mIU/mL) 6.0 (5.1–7.0) 5.7 (4.6–6.6) 6.5 (5.2–7.1) 7.0 (5.4–7.5) <0.001 5.3 ± 1.3 5.4 ± 1.3 0.78 
Other biomarkers     












(mmol/L) 1.5 (1.1–2.1) 1.7 (1.2–2.6) 1.5 (1.2–2.1) 1.3 (1.0–1.9) 0.02 2.0 ± 1.1 1.8 ± 1.3 0.42 
E2, estradiol; LH, luteinizing hormone; FSH, follicle-stimulating hormone 
 
1 Analysis of variance for continuous variables and exact chi-square tests for categorical variables were used to test associations 
between caffeine intake or ovulation status. Reproductive hormones and serum cholesterol were log transformed for normality for 
statistical analyses. 
2 Defined as having at least 1 anovulatory cycle over the 2-cycle study period.  
3Mean ± SD; all such values. 
4Median (Interquartile Range); all such values.  20
  
Figure 2.1 Percent of women consuming caffeinated and/or decaffeinated/noncaffeinated beverages, based on average intake 
captured by 8 24-hour dietary recalls across two menstrual cycles (n=259 women); and caffeine source, based on total 





17% from tea, 14% from soda, 3% from chocolate, and 0.003% from caffeinated 
medications (Figure 2.1). 
Fifty-eight percent of whites reported consuming coffee, followed by Asians 
(46%) and blacks (25%). While roughly half of all races reported consuming black tea, 
27% of Asians reported consuming green tea, followed by whites (18%) and blacks 
(12%). Blacks reported the highest frequency of soda consumption (75%), followed by 
whites (71%) and Asians (59%). Among whites, 70% caffeine came from coffee, 14% 
from tea, 13% from soda, 3% from chocolate, and 0.004% from caffeinated medications; 
while among blacks, 33% caffeine came from coffee, 40% from tea, 23% from soda, 4% 
from chocolate, and 0.001%; and among Asians, 60% caffeine came from coffee, 25% 
from tea, 12% from soda, and 4% from chocolate (no caffeinated medication was 
reported among Asians). 
Reproductive Hormones 
Interactions between race and caffeine (≥200mg/day versus <200mg/day) intake 
on total and free E2, and LH concentrations were significant (likelihood ratio test, 
P=0.01, P=0.02, and P=0.01, respectively). Similar effect modification was seen between 
race and coffee (≥1 cup/day versus <1 cup/day) intake on total and free E2, LH, and FSH 
(P=0.06, P=0.14, P=0.01, and P=0.03).  No significant interactions were found between 
caffeine and cholesterol intake, age, or waist-to-hip ratio on reproductive hormone 
concentrations.  
We observed that white women who consumed on average ≥200 mg/day of 
caffeine had lower free (and total) E2 concentrations (free E2: β=-0.15 [95% CI: -0.26, -




ratio, perceived stress, daily exercise, energy and alcohol intake, and FSH, LH, and 
progesterone concentrations (Table 2.2). In contrast, black and Asian women who 
consumed ≥ 200 mg/day of caffeine had elevated free (and total) E2 (free E2 for blacks: 
β=0.27 [95% CI: -0.01, 0.56]) and (free E2 for Asians: β=0.44 [95% CI: 0.13, 0.74]). 
Additionally, black women who consumed ≥200 mg/day of caffeine had reduced FSH 
(β=-0.36 [95% CI: -0.57, -0.14]) while Asian women had elevated LH (β=0.52 [95% CI: 
0.19, 0.85]). Sensitivity analyses showed some evidence of a dose-response: white 
women who consumed ≥400 mg/day of caffeine (n=17) had lower free (and total) E2 
concentrations (free E2, β=-0.39 [95% CI: -0.82, 0.04]) compared to white women who 
consumed less (data not shown). Too few blacks and Asians reported higher levels of 
caffeine intake to adequately assess dose-response. 
While no statistically significant associations between coffee intake ≥ 1 cup/day 
and reproductive hormones for whites and blacks were found, Asian women who 
consumed ≥ 1 cup coffee per day had elevated free (and total) E2 concentrations (free E2, 
β=0.26 [95% CI: 0.07, 0.44]) (Table 2.2). Assessment of continuous coffee intake 
(cups/day) showed similar results. As shown in Table 2.3, green (but not black) tea intake 
≥ 1 cup/day was associated with elevated free (and total) E2 (free E2, β=0.26 [95% CI: 
0.07, 0.45]) after adjusting for age, waist-to-hip ratio, perceived stress, daily exercise, 
energy and alcohol intake, and FSH, LH, and progesterone concentrations. Additionally, 
caffeinated soda intake ≥ 1 cup/day was associated with elevated free (and total) E2: (free 
E2, β=0.14 [95% CI: 0.06, 0.22]) and LH (β=0.13 [95% CI: 0.04, 0.21]) (Table 2.3).For 
each 1 cup increase in green tea consumption, free (and total) E2 concentrations 





≥200mg/day vs. <200 mg/day 
Coffee
≥ 1 cup/day vs. < 1 cup/day 
Log Hormone Model 12 Model 2 3 Model 12 Model 2 3 
E2 (ρg/mL) -0.09 (-0.19, 0.005) -0.14 (-0.25, -0.03) -0.04 (-0.14, 0.05) -0.06 (-0.16, 0.03) 
Free E2 (ρg/mL ) -0.11 (-0.21, -0.01) -0.15 (-0.26, -0.05) -0.05 (-0.14, 0.04) -0.03 (-0.07, 0.01) 
Luteal Progesterone (ng/mL) -0.01 (-0.24, 0.23) 0.00 (-0.27, 0.27) -0.06 (-0.26, 0.15) 0.04 (-0.17, 0.26) 
FSH  (mIU/mL) -0.02 (-0.10, 0.05) -0.04 (-0.12, 0.04) 0.03 (-0.05, 0.10) 0.02 (-0.05, 0.10) 
LH (ng/mL) -0.04 (-0.15, 0.06) -0.12, (-0.23, -0.002) -0.05 (-0.15, 0.05) -0.06 (-0.16, 0.03) 
BLACK (n=92 cycles) Caffeine  
≥200mg/day vs. <200 mg/day 
Coffee
≥ 1 cup/day vs. < 1 cup/day 
Log Hormone Model 12 Model 2 3 Model 12 Model 2 3 
E2 (ρg/mL) 0.14 (-0.16, 0.45) 0.24 (-0.05, 0.53) -0.03 (-0.28, 0.22) -0.03 (-0.25, 0.20) 
Free E2 (ρg/mL ) 0.17 (-0.14, 0.47) 0.27 (-0.01, 0.56) 0.003 (-0.24, 0.25) -0.01 (-0.23, 0.21) 
Luteal Progesterone (ng/mL) 0.04 (-0.56, 0.65) -0.10 (-0.74, 0.55) -0.05 (-0.56, 0.47) -0.05 (-0.56, 0.46) 
FSH  (mIU/mL) -0.36 (-0.59, -0.14) -0.36 (-0.57, -0.14) -0.06 (-0.24, 0.13) -0.08 (-0.25, 0.09) 
LH (ng/mL) -0.06 (-0.39, 0.28) -0.08 (-0.39, 0.24) 0.08 (-0.19, 0.35) -0.003 (-0.25, 0.24) 
   
   
   
   
   
   
Table 2.2: Mean difference in log serum concentrations of reproductive hormones stratified by race of participants 















E2, estradiol; LH, luteinizing hormone; FSH, follicle-stimulating hormone 
 
1Coffee includes caffeinated (98%) and decaffeinated (2%); Anovulation is any cycle with peak progesterone concentration ≤ 5 ng/mL 
and no observed serum LH peak on the mid or late luteal phase visits. There were 433 ovulatory cycles among whites, blacks and 
Asians. Analyses were performed using linear mixed effects models on the log scale of hormones. Interactions between race and 
caffeine (≥200mg/day versus <200mg/day) intake on total and free E2, and LH concentrations were significant (likelihood ratio test, 
P=0.01, P=0.02, and P=0.01, respectively) as well as between race and coffee (≥1 cup/day versus <1 cup/day) intake on total and free 
E2, LH, and FSH (P=0.06, P=0.14, P=0.01, and P=0.03). 
2Adjusted for age, waist-to-hip ratio, perceived stress, daily exercise, energy and alcohol intake (all continuous). 
3Adjusted for age, waist-to-hip ratio, perceived stress, daily exercise, energy and alcohol intake, and relevant phase-specific hormone 
concentrations using inverse probability of exposure weights. 
 
 
ASIAN (n=64 cycles) Caffeine  
≥200mg/day vs. <200 mg/day 
Coffee
≥ 1 cup/day vs. < 1 cup/day 
Log Hormone Model 12 Model 2 3 Model 12 Model 2 3 
E2 (ρg/mL) 0.44 (0.15, 0.73) 0.61 (0.31, 0.92) 0.35 (0.16, 0.54) 0.32 (0.13, 0.51) 
Free E2 (ρg/mL ) 0.27 (-0.02, 0.56) 0.44 (0.13, 0.74) 0.28 (0.09, 0.47) 0.26 (0.07, 0.44) 
Luteal Progesterone (ng/mL) 0.18 (-0.60, 0.96) 0.28 (-0.60, 1.17) -0.21 (-0.66, 0.25) -0.11 (-0.56, 0.34) 
FSH (mIU/mL) 0.20 (-0.02, 0.42) 0.17 (-0.06, 0.40) 0.19 (0.04, 0.33) 0.11 (-0.04, 0.25) 






Table 2.3: Mean difference in log serum concentrations of reproductive hormones 
according to participants’ beverage intake (n=467 ovulatory cycles)1 
 
 Black Tea 
≥ 1 cup/day vs. < 1 cup/day 
Log Hormone Model 12 Model 2 3 
E24 (ρg/mL) -0.02 (-0.09, 0.06) 0.002 (-0.08, 0.08) 
Free E24 (ρg/mL) -0.01 (-0.08, 0.07) 0.01 (-0.08, 0.09) 
Luteal Progesterone 
(ng/mL) -0.08 (-0.26, 0.11) -0.05 (-0.26, 0.16) 
FSH4  (mIU/mL) 0.04 (-0.02, 0.10) 0.04 (-0.02, 0.10) 
LH4 (ng/mL) 0.05 (-0.04, 0.14) 0.03 (-0.06, 0.12) 
 Green Tea
≥ 1 cup/day vs. < 1 cup/day 
Log Hormone Model 12 Model 2 3 
E24 (ρg/mL) 0.15 (-0.004, 0.31)  0.28 (0.09, 0.47) 
Free E24 (ρg/mL ) 0.14 (-0.02, 0.30)  0.26 (0.07, 0.45) 
Luteal Progesterone 
(ng/mL) 0.02 (-0.32, 0.36) -0.13 (-0.59, 0.33) 
FSH4  (mIU/mL) -0.10 (-0.22, 0.02) -0.04 (-0.18, 0.10) 
LH4 (ng/mL) 0.01 (-0.16. 0.18) 0.09 (-0.11. 0.30) 
 Caffeinated Soda 
≥ 1 cup/day vs. < 1 cup/day 
Log Hormone Model 12 Model 2 3 
E24 (ρg/mL) 0.11 (0.03, 0.19) 0.15 (0.07, 0.23) 
Free E24 (ρg/mL ) 0.10 (0.03, 0.18) 0.14 (0.06, 0.22) 
Luteal Progesterone 
(ng/mL) -0.04 (-0.22, 0.15) -0.10 (-0.30, 0.10) 
FSH4  (mIU/mL) 0.01 (-0.05, 0.07) 0.03 (-0.03, 0.09) 
LH4 (ng/mL) 0.08 (-0.003, 0.16) 0.13 (0.04, 0.21) 
E2: estradiol; LH: luteinizing hormone; FSH: follicle stimulating hormone 
 
1 Anovulation is any cycle with peak progesterone concentration ≤ 5 ng/mL and no 
observed serum luteinizing hormone peak on the mid or late luteal phase visits. There 
were 467 ovulatory cycles among all BioCycle Study participants. Analyses were 




Table 2.3 continued 
 
2 Adjusted for age (continuous); race (white, black, Asian, other); waist-to-hip ratio 
(continuous); perceived stress (continuous); daily exercise (continuous); energy and 
alcohol intake (continuous). 
3Adjusted for age,  race, waist-to-hip ratio, perceived stress, daily exercise, energy and 
alcohol intake, and relevant phase-specific hormone concentrations using inverse 





showed that LH concentrations were not associated with each 1 cup increase of 
caffeinated soda intake, but that free (and total) E2 concentrations increased (free E2, 
β=0.04 [95% CI: 0.001, 0.08]) (data not shown). Results were similar when including the 
anovulatory cycles (n=42 cycles) or when restricting analyses to nonsmokers (n=218 
women) for all models. 
Similar relationships, with some differences in patterns, were observed using the 
nonlinear harmonic models. While intake of ≥ 200 mg/day of caffeine and ≥ 1 cup/day of 
coffee was associated with decreased mean concentrations of free E2 for white women 
(β=-0.09 [95% CI: -0.18, -0.01]) and  (β=-0.10 [95% CI: -0.17, -0.02]), respectively; 
increased amplitude in free E2 was observed for Asian women who consumed  ≥ 200 
mg/day of caffeine (β=0.39 [95% CI: 0.01, 0.77]) and ≥ 1 cup/day of coffee  (β=0.29 
[95% CI: 0.12, 0.47]), compared to women who consumed less (Figure 2.2 and Figure 
2.3). White and Asian women also had a significant free E2 phase shift with coffee intake 
≥1 cup/day, although in different directions. Whites peaked later (β=0.05 [95% CI: 0.03, 
0.08]) while Asians peaked earlier (β=-0.10 [95% CI: -0.16, -0.04])) (Figure 2.3). The 
relationship between mean caffeinated soda consumption (≥1 cup versus < 1 cup) and 
free E2 concentrations among all races mirrored the mixed model results (β=0.11, [95% 
CI: 0.03, 0.19])) (Figure 2.4). Similar trends were seen for free and total E2 and no 
further statistically significant differences in hormonal patterns for other caffeinated 
beverages were found in the harmonic models. 
  
Figure 2.2: Adjusted mean serum concentrations of free estradiol across the menstrual cycle for white and Asian women 





































































Figure 2.3: Adjusted mean serum concentrations of free estradiol across the menstrual cycle for white and Asian women 





































































Figure 2.4: Adjusted mean serum concentrations of total and free estradiol across the menstrual cycle of estradiol and free 







































































Green tea intake (≥1 cup/day versus (vs.) <1 cup/day) was associated with 
increased odds of anovulation (adjusted odds ratio (aOR) = 4.14 [95% CI: 1.26, 13.60]); 
however, results lacked precision because only 16% (n=42 women) reported consuming 
≥1 cup/day green tea on at least 1 of their 24HDRs. No further significant associations 
between caffeine (≥200 mg/day vs. <200 mg/day) and caffeinated beverages (≥1 cup/day 
vs. <1 cup/day) and ovulatory function were found (Table 2.4). Sensitivity analyses for 
caffeine (≥100, ≥300, ≥400 mg/day) and all caffeinated beverages (1-cup increments) 
indicated that 2 or more cups of coffee per day was marginally associated with decreased 
odds of anovulation (aOR=0.23 [95% CI: 0.05, 1.02]) (data not shown). Assessing 
anovulation based on the less conservative definition (progesterone ≤ 5 ng/mL) did not 
alter the findings from our initial analyses nor did restricting the analyses to nonsmokers.  
Discussion 
We observed that caffeine intake was significantly associated with premenopausal 
reproductive hormone concentrations and varied across race/ethnicity groups. Higher 
caffeine intake was associated with decreased free E2 concentrations among whites and 
increased free E2 concentrations among Asians. Though we observed differences by race, 
these results are based on a relatively small sample size and should be interpreted with 
caution. In addition, caffeinated soda and green tea intake was positively associated with 
increases in total and free E2 concentrations among all races. Caffeine intake above the 
recommended levels was not associated with anovulation; however, green tea intake ≥ 1 
cup/day was associated with increased odds for anovulation.
  
Table 2.4: Odds of anovulation1 according to recommended levels of caffeine [≥200mg/day (high) vs <200mg/day (low)] and 
beverage intake [(≥1 cup/day (high) vs <1 cup/day(low)]2 
 
  Multivariate adjusted OR (95% CI)3 
Caffeine  ≥200mg/day vs. <200 mg/day 0.82 (0.31, 2.21) 
Coffee ≥ 1 cup/day vs. < 1 cup/day 0.56 (0.22, 1.40) 
Black Tea ≥ 1 cup/day vs. < 1 cup/day 0.74 (0.32, 1.70) 
Green Tea ≥ 1 cup/day vs. < 1 cup/day 4.14 (1.26, 13.60) 
Caffeinated Soda ≥ 1 cup/day vs. < 1 cup/day 0.76 (0.30, 1.94) 
 
1Defined as peak progesterone concentrations ≤5 ng/mL and no observed serum LH peak on days 22 or 27 of standardized 28-day 
cycle (n=42 of 509 cycles (8.3%)). Twenty-eight women had 1 anovulatory cycle; 7 women had 2 anovulatory cycles. 
2 Intake assessed at 4 times each cycle:  menses, mid-follicular, ovulation and mid-luteal clinic visits via 24-hour dietary recall. 
Analyses performed using generalized linear mixed models. 
3Adjusted for age (continuous); race (white, black, Asian, other); waist-to-hip ratio (continuous); perceived stress (continuous); daily 






Our finding of an inverse association between caffeine and free E2 concentrations 
in premenopausal white women concurs with 2 studies. Kotsopoulos et al. examined free 
E2 plasma concentrations among 524 predominately white (13) women and found an 
inverse association between caffeine and luteal free E2 (6). Similarly, Choi et al. found a 
significant inverse association between increased caffeine intake and decreased peak E2 
in 2474 women (race not specified) undergoing infertility treatment (43). In contrast, 
Lucero et al. found caffeine intake associated with increasing early follicular E2 in 498 
predominately white (97%) premenopausal women (4). Kinney et al. found no 
association between caffeine and early follicular phase total E2 in a study of 188 
predominately white (95%) premenopausal women (5), while Nagata et al. found no 
significant association between caffeine and follicular or luteal E2 among college-aged 
Asian women (n=50) (3). Comparing these latter 3 studies to ours is limited since they 
measured caffeine via a single food frequency questionnaire and obtained at most 2 
serum samples per cycle without using a validated method to time menstrual cycle phase. 
Since menstrual cycle phase has been shown to affect caffeine metabolism (44), women’s 
caffeine intake may vary, thus demonstrating the need to capture acute versus habitual 
patterns when assessing the effect of caffeine on reproductive hormone concentrations. 
Similar associations of coffee and caffeine on E2 both in our study and others (6) 
suggest that caffeine is the component influencing estrogen metabolism. While we did 
not measure testosterone, evidence has shown higher testosterone concentrations with 
higher caffeine and coffee intake (6), supporting the hypothesis that caffeine’s effect on 
estradiol is via aromatase inhibition (6, 19).  Estrogen metabolism has also been shown to 




gene-environment interactions may partially explain these differences (28-30). CYP1A2 
genotypes have been shown to have interethnic variability, with Asians and Africans 
appearing to metabolize caffeine more slowly than whites (10, 37). Our results showing 
higher E2 concentrations among Asians and blacks with higher caffeine intake might be 
due to CYP polymorphisms, but corroboration by other studies is lacking, and we did not 
directly measure genotype. Additionally, race as a construct represents a complex 
interplay between many social, lifestyle, environmental, and genetic factors.  Further 
studies are needed to explore differences in the effects of caffeine on reproductive 
hormones by race.   
 Despite evidence that elevated or insufficient E2 concentrations can inhibit 
ovulation (15), we found no association between caffeine, coffee, and anovulation. Our 
finding corroborates with previous studies (16, 20, 21) and suggests that even though 
moderate caffeine and coffee intake may alter E2, these alterations are not within a range 
as to affect ovulatory function. Our results are in line with Choi et al.’s finding that 
despite lower E2 concentrations in women with moderate-to-high caffeine intake, the 
number of oocytes retrieved did not differ by caffeine category (43). Recent systematic 
reviews do not support a positive relationship between caffeine consumption and adverse 
reproductive outcomes (45, 46). 
The effects of tea on reproductive hormones have not been well studied. One 
study, restricted to Asian women, differentiated exposure by tea type and found green tea 
to be inversely correlated with follicular estradiol (3). In contrast, women of all races in 
the BioCycle Study (including Asian women) had statistically elevated free E2 for intake 




anovulation, a finding supported by animal research (47). Increases in E2 in response to 
green tea intake may also lead to an increase in oxidative stress (48), thus requiring more 
antioxidants to compensate for the increase in oxidative stress. Given that green tea is 
high in antioxidants and recent evidence suggests that antioxidants adversely affect 
ovulatory function (49) further research is justified. Caution is warranted regarding the 
marginal association we found between anovulation and green tea due to limited intake 
among study participants and lack of comparative studies. 
 Our finding that soda intake significantly increases E2 concentrations is novel, but 
mirrors results from animal studies. Celec et al. found intake of 3 different sweetened 
cola drinks to be associated with increased E2 concentrations in adult male Wistar rats 
(n=40) (50). The only other human study that we are aware of investigating soda and 
premenopausal E2 concentrations found no effect after adjusting for age, BMI, and cycle 
length, but restricted their investigation to cola and had a small sample size (n=50) and 
limited exposure/outcome assessment (3).   
The BioCycle Study has several strengths, including multiple measures of 
hormone assessment over 2 menstrual cycles (using standardized methods to time cycle 
phase) and multiple measures of not only caffeine and caffeinated beverage intake, but 
important dietary and lifestyle factors as well. While self-report of diet is subject to 
measurement error (51-53), our study used multiple validated 24HDRs to reduce the 
potential for exposure misclassification. 
Nevertheless, the study had several limitations including the low percentage of 
women who consumed ≥ 200 mg/day of caffeine and ≥ 1 cup/day of caffeinated 




caffeine, 19 oz of soda, 6 oz of coffee, and 5 oz of tea (1, 54) whereas the BioCycle 
Study participants daily consumed on average 91 mg of caffeine, 3 oz of soda, 4 oz of 
coffee, and 3 oz of tea. Additionally, while the BioCycle Study had greater racial 
diversity than comparable studies (3-6), our study was limited by different sample sizes 
among the racial groups, which may have limited our power to detect significant 
differences in some of our subgroup analyses.  
In conclusion, within moderate ranges of consumption, caffeine was associated 
with reduced E2 concentrations among white women and elevated E2 concentrations 
among Asian women. Caution regarding effect modification by race in this study is 
warranted due to limited numbers of Asians with high exposure. Understanding the 
relationship between caffeine and E2 has substantial implications for women’s health, 
both in regard to reproductive health and hormonally dependent cancers. Higher 
concentrations of E2 are found in women with endometriosis, a well-known risk factor 
for infertility (55). Additionally, there is evidence for increased risk of breast cancer with 
increased E2 concentrations among premenopausal women (56) and possibly for 
endometrial and ovarian cancers as well (12). Furthermore, bone mineral density is 
known to have interethnic/race variation and may be influenced by sex hormones (57-
59). Given these public health implications, further research investigating whether 
caffeine or other components in caffeinated beverages play a role in reproductive 
hormone synthesis is needed, as well as evaluation as to whether these relationships differ 
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FRUCTOSE-RICH BEVERAGES: REPRODUCTIVE HORMONES  
AND OVARIAN FUNCTION IN THE BIOCYCLE STUDY 
Abstract 
Fructose-rich beverages are widely consumed among women of reproductive age 
but their association with reproductive function is not well understood. Our objective was 
to assess the association of added sugars, fructose, and beverage intake with reproductive 
hormones and sporadic anovulation in healthy premenopausal women. Women (n=259) 
in the BioCycle Study were followed for up to 2 menstrual cycles, providing fasting 
blood specimens at up to 8 visits/cycle and 4 24-hour dietary recalls/cycle. Participants 
who consumed more added sugar than an average American woman (≥ 73.2 grams/day) 
or above the 66th percentile in fructose intake (≥ 41.5 grams/day) had elevated free 
estradiol (E2), follicular stimulating hormone (FSH) and luteinizing hormone (LH) 
concentrations compared to women who consumed less after adjusting for age, waist-to-
hip ratio, race, dietary factors, physical activity, and relevant hormones. No associations 
were found between intakes above the American Heart Association’s recommended 
limits for added sugar intake (≥ 40 grams/day) and reproductive hormone levels across 
the cycle. Women who consumed ≥1 cup/day of sweetened soda had elevated free E2 
(β=0.15 [95% CI: 0.06, 0.24]. Neither artificially sweetened soda intake nor fruit juice 




associations were found between added sugars, fructose or beverage intake and 
anovulation. Even at moderate consumption levels, added sugars, total fructose, and 
sweetened soda were associated with elevated E2 concentrations among premenopausal 
women. Further research into whether fructose alone or in conjunction with other 
components in sweetened soda is associated with sex hormones is warranted. 
Introduction 
Sweetened soda intake, the largest contributor of fructose in the American diet 
(whether sweetened with sugar or high fructose corn syrup), has markedly increased over 
the last few decades rising from roughly 2 8-oz servings/week in 1942 to roughly 2 8-oz 
servings/day in 2000 (1). Women of childbearing age in the United States derive on 
average over 23% of their daily energy from beverage sources (2). Due to overwhelming 
experimental and epidemiologic evidence indicating that sweetened beverages are 
associated with weight gain, metabolic syndrome, and cardiovascular risk factors (3-5), 
the American Heart Association (AHA) recently expanded its recommendation to limit 
intake of added sugars by proposing specific values depending on age, gender, and 
physical activity (6). According to the AHA, an adult woman who is moderately 
physically active, age 19–30, should limit her consumption of added sugars to between 8 
to 12 teaspoons/day (≈32–48 grams(g)/day), equivalent to approximately a 12-oz can of 
nondiet soda, significantly below the current usual intake for an adult American woman 
of 18.3 teaspoons/day (73.2 g/day) (6).  
While both human and animal studies have shown that diets high in fructose 
result in dyslipidemia and insulin resistance (7-12), well-known risk-factors for hormone 




fructose on premenopausal reproductive hormone levels (14, 15) and ovulatory function 
(13) is sparse. Studies have found no association between soda and premenopausal 
reproductive hormones, but inferences have been limited by small sample sizes and/or 
inadequate methods to evaluate the phase of the menstrual cycle when the hormones were 
measured. Women participating in the Nurses’ Health Study who consumed ≥ 2 8-ounce 
(oz) cups/day of caffeinated soda were recently shown to have an increased relative risk 
(RR=1.47, 95% CI: 1.09–1.98) for ovulatory disorder compared to women who 
consumed < 1 8-oz cup/week, (13), but no significant results with total caffeine nor with 
caffeinated coffee or tea were found. These findings suggest that relevant components 
may be specific to soda. The relationship between these components and sex hormones is 
of interest for assessing not only their effects on female reproductive function (13), but 
also for better understanding hormone-related chronic diseases (16).  
The objective of this study is to determine whether added sugars, fructose, and 
sweetened or artificially sweetened beverage intake are related to serum concentrations of 
reproductive hormones and ovulatory function in a cohort of 259 healthy, premenopausal 
women, using a standardized method to time serum sample collections according to the 
phase of the menstrual cycle.  
Subjects and Methods 
Study Population 
The BioCycle Study, conducted in 2005–2007, followed 259 women from 
western New York State for up to 2 complete menstrual cycles. The study population, 
materials and methods have been previously described in detail (17). In summary, healthy 




21 and 35 days for each menstrual cycle in the past 6 months) to participate. Women 
reporting conditions known to affect menstrual cycle function such as polycystic ovary 
syndrome, uterine fibroids, or current or recent use of hormonal contraception (i.e., 3 
months prior to study entry) were excluded. Women with previously known ovulatory 
disorders were excluded, but sporadic anovulation (n=35 women, 42 cycles) was 
observed in the study population (18). The University at Buffalo Health Sciences 
Institutional Review Board (IRB) approved the study and served as the IRB designated 
by the National Institutes of Health for this study under a reliance agreement. Written 
informed consent was obtained from all participants. 
Hormone Assessment 
Women provided fasting blood specimens on up to 8 visits/cycle for 1 (n=9) or 2 
(n=250) menstrual cycles, with visit timing assisted by use of fertility monitors to 
correspond to menstruation, mid-follicular, late follicular, luteinizing hormone 
(LH)/follicle stimulating hormone (FSH) surge, ovulation, early luteal, mid-luteal, and 
late luteal phases (19). Total estradiol (E2) was measured via radio immunoassay while 
progesterone, LH, FSH, and sex hormone binding globulin (SHBG) were measured using 
solid-phase competitive chemiluminescent enzyme immunoassay (Immulite 2000). The 
albumin assay was tested on the Beckman LX20 auto analyzer using bromcresol purple 
methodology. Calculation of free E2 (i.e., bioavailable E2) was performed via the 
equation proposed by Sodergard et al. using total E2, SHBG, and albumin concentrations 
(20). All hormonal analyses were conducted by Kaleida Health Laboratories in Buffalo, 
New York.  Across the study period, the coefficient of variation (CV) for these tests was 




progesterone. We defined anovulation as any cycle with peak progesterone concentration 
≤ 5 ng/mL and no observed serum LH peak on the mid or late luteal phase visits (n=42 of 
509 cycles (8.3%)). Study protocol compliance was high, with 94% of the participants 
completing 7 or 8 visits/cycle.  
Dietary Assessment 
Participants completed a 24-hour dietary recall (24HDR) at the clinic after fasting 
blood specimen collection during the 4 visits corresponding to menstruation, mid-
follicular phase, ovulation and mid-luteal phase. Food and beverage intake (including 
sweetened and artificially sweetened (diet) sodas, and citrus and noncitrus fruit juices) 
was collected and nutrient data were analyzed using the Nutrition Data System for 
Research (NDSR, 2005, Nutrition Coordinating Center, University of Minnesota, 
Minneapolis, MN). We assessed citrus and noncitrus juice separately since grapefruit 
juice has been shown to increase endogenous estrogen levels (21). In addition to total 
sugars and added sugars, the NDSR provides information on daily free fructose and 
sucrose intake. Since half of the disaccharide sucrose is fructose (which is split from 
glucose in the small intestine), we calculated total fructose equal to the intake of free 
fructose plus half the intake of sucrose (22). Further abstraction was done from the raw 
24HDR data to discriminate between cola and noncola soda since this information is not 
included in standard NDSR output and caramel coloring agents in colas are thought to 
affect health outcomes (23-25). Compliance was high with 87% completing 4 dietary 





At study enrollment, adiposity measurements, including body mass index (BMI) 
and waist-to-hip ratio were obtained by trained study staff using standardized protocols, 
while age, race, and reproductive history were obtained using validated questionnaires 
(17).  For prospectively measured covariates, participants were provided a diary where 
they were instructed to record daily vigorous exercise (minutes) and cigarettes smoked 
(number). The majority of participants (89%) completed at least 75% of their daily 
diaries. 
Statistical Analyses  
Descriptive statistics were compared between tertiles of daily fructose intake and 
recommended limits (≤ 1 cup) of sweetened soda intake, averaged over the 2 cycles 
under study. We assessed differences using analysis of variance per the Satterthwaite 
method for unequal variances and exact chi-square tests where appropriate (26). 
Reproductive hormone levels were log transformed for statistical analyses. Weighted 
linear mixed models were used to evaluate the association between added sugars, 
fructose, soda (sweetened or artificially sweetened; cola and noncola), and juice intake 
(15) and log serum concentrations of free and total E2, luteal progesterone, LH and FSH. 
Generalized linear mixed models were used to estimate the odds of anovulation based on 
fructose, added sugars and beverage consumption. We assessed the association between 
intakes above the AHA recommended added sugar intake levels for moderately 
physically active American women, age 19-30, (≥40.0 g/day versus <40.0 g/day) (27), as 
well as intakes above the usual added sugar intake for American women (≥73.2 g/day 




compared cutpoints at the 33rd percentile (≥ 28.4 g/day versus <28.4 g/day), 50th 
percentile (median) (≥ 33.5 g/day versus <33.5 g/day), and 66th percentile (≥ 41.5 g/day 
versus <41.5 g/day) for total fructose, and (≥ 1 cup/day versus < 1 cup/day) sweetened or 
artificially sweetened beverages (15). Random-intercepts were included in the models to 
account for between-women variation in baseline hormone concentrations and within-
woman correlations across cycles. Models evaluating reproductive hormones were 
restricted to ovulatory cycles (18) as the hormonal patterns for anovulatory cycles are 
distinctly different from ovulatory cycles. 
Potential confounders were determined a priori using directed acyclic graphs 
(DAG). Age (continuous), waist-to-hip ratio (continuous), race (white, black, Asian and 
other), total energy intake (continuous), physical activity (continuous), and a previously 
described (28) dietary quality score (alternate Mediterranean Diet Score; continuous) 
were included in our final models. For all models of soda intake, we also adjusted for 
total caffeine intake. Additional covariates including other beverages consumed, cigarette 
use, and gravidity were considered but did not appreciably alter the estimates (29), nor 
did adjusting for BMI versus waist-to-hip ratio. Based on our proposed DAG, the 
minimum set of confounders we adjusted for accounts for all sources of measured and 
known confounding. Since E2, progesterone, LH, and FSH levels change over the cycle 
in response to complex feedback mechanisms with other hormones, traditional regression 
adjustment for other hormone levels is inadequate. Therefore, we additionally present 
models that adjust for other reproductive hormones through stabilized inverse probability 




To assess how fructose and fructose-rich beverage intake affect hormonal 
patterns, we used nonlinear mixed models with harmonic terms. While the linear mixed 
models allow for estimation of mean differences, these harmonic models can additionally 
evaluate differences in amplitude (i.e., difference between nadir and peak concentrations) 
and timing of phase shifts while taking into account between and/or within subject 
variation (32).  
Sensitivity analyses were conducted to assess the effects of continuous beverage 
intake (1 cup increments) on reproductive hormones and anovulation.  For reproductive 
hormones, we additionally assessed effects of including anovulatory cycles. For 
anovulation, we assessed the effects of fructose or fructose-rich beverages on a less 
conservative classification of anovulation defined as cycles with progesterone 
concentrations ≤ 5 ng/mL (n=65 of 509 cycles (12.8%)).   
Results 
Fructose and Beverage Consumption 
Mean intake of added sugars and total fructose across both cycles were 57.2 ± 
26.9 g/day and 35.4 ± 13.7 g/day, respectively. Fructose intake over the study period was 
positively associated with black race, total energy intake, percent calories from 
carbohydrates, added sugars and fiber intake and inversely associated with percent 
calories from protein. Sweetened soda intake was positively associated with black race, 
fructose and added sugar intake and both E2 and free E2 concentrations and inversely 
associated with daily exercise, alcohol, fiber intake, and percent calories from protein 
(Table 3.1).  Over 2 cycles, 69% consumed soda (52% exclusively sweetened, 27%  
  
Table 3.1: Characteristics of women participating in the BioCycle Study by average fructose1 and sweetened soda intake 
across 2 menstrual cycles  
 
  Fructose Intake (g/day)  Sweetened Soda Intake
 Total <28.4 28.4-41.5 >41.5 P <1 cup ≥ 1cup P 
Number of participants  
[n (%)] 259 86 (33.2) 88 (34.0) 85 (32.8)  244 (94.2) 15 (5.8)  
Demographic/Lifestyle    
Age (years)  27.3 ± 8.22 26.8 ± 8.1 27.0 ± 8.0 28.1 ± 8.6 0.54 27.3 ± 8.3 26.5 ± 7.1 0.71 
Race[n (%)] 0.02   0.01 
     White 154 (59.5) 43 (50.0) 60 (68.2) 51 (60.0) 
 
147 (60.3) 7 (46.7)  
     Black 51 (19.7) 16 (18.6) 13 (14.8) 22 (25.9) 43 (17.6) 8 (53.3)  
     Asian 37 (14.3) 21 (24.4) 10 (11.4) 6 (7.1) 37 (15.2) 0 (0.0)  
     Other 17 (6.6) 6 (7.0) 5 (5.7) 6 (7.1) 17 (7.0) 0 (0.0)  
BMI (kg/m2)  24.1 ± 3.9 23.8 ± 3.9 24.3 ± 3.8  24.1 ± 3.9 0.74 24.0 ± 3.8 25.3 ± 4.1 0.20 
Waist-to-hip ratio  0.75 ± 0.06 0.74 ± 0.05 0.75 ± 0.06 0.75 ± 0.05 0.31 0.75 ± 0.06 0.78 ± 0.06 0.08 
Nulligravid [n (%)] 177 (69.4) 60 (72.3) 63 (72.4) 54 (63.5) 0.35 165 (68.8) 12 (80.0) 0.56 
Cigarette Use [n (%)] 0.25   0.48 
    No 218 (84.2) 71 (83.0) 71 (81.0) 76 (89.4) 
 
204  (83.6) 14 (93.3)  
    Yes 41 (15.8) 15 (17.4) 17 (19.3) 9 (10.6) 40 (16.4) 1 (6.7)  
Vigorous exercise (min/day)  14.7 ± 21.9 16.9 ± 24.8 15.6 ± 18.7 11.7  ± 21.9 0.26 15.4 ± 22.4 4.7 ± 5.0 <0.001 
Diet     
Total energy (kcal) 1613.3 ± 367.3 1378.9 ± 320.5 1649.4 ± 322.0 1813.1 ± 324.0 <0.001 1602.6 ± 366.2 1786.9 ± 353.1 0.06 
Alcohol  (grams) 2.8 ± 5.5 3.1 ± 7.0 3.1 ± 5.4 2.1 ± 3.3 0.37 2.9 ± 5.6 1.1 ± 1.7 0.004 
Carbohydrates (% calories) 50.8 ± 7.3 47.5 ± 7.8 51.3 ± 7.0 53.6 ± 5.5 <0.001 50.7 ± 7.3 52.0 ± 7.0 0.52 
Protein (% calories) 15.8 ± 3.1 17.5 ± 3.4  15.6 ± 2.5 14.3 ± 2.5 <0.001 15.9 ± 3.1 14.0 ± 2.1 0.02 
Fat (% calories) 33.8 ± 5.6 34.9 ± 6.2 33.6 ± 5.4 32.9 ± 4.9 0.06 33.7 ± 5.6 34.6 ± 6.1 0.56 
52
  
Table 3.1 continued         
  Fructose Intake (g/day)  Sweetened Soda Intake  
 Total <28.4 28.4-41.5 >41.5 P <1 cup ≥ 1cup P 
Fiber (g/day) 13.6 ± 5.6 11.8 ± 4.3 15.0 ± 6.0 14.1 ± 5.8 <0.001 13.9 ± 5.6 9.4 ± 3.4 0.001 
Fructose (g/day) 17.2 ± 9.2 20.8 ± 5.1 34.5  ± 4.1 51.2 ± 7.9 <0.001 34.2 ± 12.9 55.3 ± 11.8 <0.001 
Added sugars (g/day) 57.2 ± 26.9 32.8 ± 12.9 55.9 ± 14.7 83.3 ± 23.2 <0.001 55.0 ± 25.6 93.5 ± 22.0 <0.001 
Reproductive Hormones         











Free E2 (ρg/mL) 1.3 (1.1–1.6) 1.3 (1.1-1.6)  1.3 (1.0-1.5)  1.3 (1.1-1.7)  0.43 1.3 (1.0-1.6) 1.6 (1.3-1.9) 0.01 
Luteal Progesterone (ng/mL) 3.4 (2.5–4.4) 3.8 (2.4-4.5)  3.1 (2.4-4.1)  3.3 (2.7-4.5)  0.06 3.4 (2.5-4.4) 3.4 (2.9-4.5) 0.28 
LH (ng/mL) 9.2 (7.5–11.4) 10.1 (7.9-11.6) 8.8 (7.4-11.4)  9.0 (7.4-10.9)  0.15 9.2 (7.5-11.3) 10.7 (7.2-12.2) 0.74 
FSH (mIU/mL) 6.0 (5.1–7.0) 6.0 (5.2-6.9) 6.1 (5.2-7.2) 5.9 (4.9-6.9) 0.15 6.0 (5.2-7.0) 5.2 (4.6-6.7) 0.18 
BMI, body mass index; E2, estradiol; FSH, follicle-stimulating hormone; LH, luteinizing hormone. 
1 Intake assessed at 4 times each cycle:  menses, mid-follicular, ovulation and mid-luteal clinic visits via 24-hour dietary recall. 
Fructose equal to the intake of free fructose plus half the intake of sucrose 
2Calculated by using student’s t-test for continuous variables (Satterthwaite method when variance unequal) and exact chi-square tests 
for categorical variables. Reproductive hormones were log transformed for normality for statistical analyses. 
3Mean ± SD; all such values. 






exclusively artificially sweetened, and 21% both sweetened and artificially sweetened), 
and 81% consumed fruit juice (59% exclusively citrus, 11% exclusively noncitrus fruit 
juice and 30% both citrus and other fruit juice). 
Reproductive Hormones 
Women above the 66th percentile in fructose intake (41.5 g/day) had elevated free 
E2, FSH, and LH concentrations compared to women consuming <41.5 g/day (Table 
3.2), but no statistically significant differences were found at the 33rd or 50th percentiles 
(data not shown). While no statistically significant associations were found between 
consumption above the AHA recommended added sugar intake levels (≥ 40.0 g/day 
versus < 40.0 g/day) and reproductive hormone levels across the menstrual cycle, those 
who consumed more added sugar than American women on average (≥ 73.2 g/day) had 
elevated free and total (marginal) E2, FSH, and LH compared to women who consumed 
<73.2 g/day after adjusting for age, waist-to-hip ratio, race, total energy intake, physical 
activity, dietary quality score, and relevant hormones (Table 3.2). Consumption of  ≥ 1 
cup/day of sweetened soda was associated with elevated free and total E2 concentrations 
(free E2: β=0.15 [95% CI: 0.06, 0.24]) compared to women who consumed <1 cup/day 
after multivariate adjustment, including total caffeine intake (Table 3.3). Results were 
similar for cola and noncola intake, with consumption ≥ 1 cup/day associated with 
elevated free and total E2 concentrations. Neither intake of artificially sweetened soda 
nor fruit juice ( ≥ 1 cup/day versus <1 cup/day) was significantly associated with 
reproductive hormone concentrations (Table 3.3). Sensitivity analyses showed that for 
each 1-cup increment in sweetened soda intake, free (and total) E2 increased (free E2:  
  
Table 3.2: Mean difference in log serum concentrations of reproductive hormones according to added sugar and fructose 
intake (n=467 ovulatory cycles)1 
E2, estradiol; FSH, follicle-stimulating hormone; LH, luteinizing hormone. 
 
1Anovulation is any cycle with peak progesterone concentration ≤ 5 ng/mL and no observed serum LH peak on the mid or late luteal 
phase visits (n=42 cycles). Nutrient intake assessed at 4 times each cycle: menses, mid-follicular, ovulation and mid-luteal clinic visits 
via 24-hour dietary recall. Fructose equal to the intake of free fructose plus half the intake of sucrose. 
2Adjusted for age, waist-to-hip ratio, race, total energy intake, dietary quality score, and physical activity using linear mixed effects 
models on the log scale of hormones.  
3 Adjusted for age, waist-to-hip ratio, race, total energy intake, dietary quality score, physical activity and relevant phase-specific 




≥ 40.0 vs < 40.0 g/day 
AHA Recommended Limit 
Added Sugars 
≥ 73.2 vs < 73.2 g/day 
Usual Intake for American Women 
Fructose
≥ 41.5 vs < 41.5 g/day 
66th Percentile 
Log Hormone Model 12 Model 2 3 Model 12 Model 2 3 Model 12 Model 2 3 
Total E2 (ρg/mL) 0.04 (-0.02, 0.10) 0.04 (-0.02, 0.10) 0.07 (0.01, 0.14)4 0.05 (-0.01, 0.11) 0.06 (-0.004, 0.12) 0.04 (-0.02, 0.10) 
Free E2 (ρg/mL ) 0.03 (-0.03, 0.09) 0.04 (-0.02, 0.10) 0.07 (0.01, 0.14)4 0.06 (0.004, 0.13)4 0.07 (0.01, 0.13)4 0.06 (0.002, 0.12)4 
Luteal Progesterone 
(ng/mL) 0.08 (-0.07, 0.23) 0.06 (-0.09, 0.21) 0.06 (-0.11, 0.23) 0.07 (-0.11, 0.25) 0.01 (-0.14, 0.1) -0.11 (-0.27, 0.05) 
FSH  (mIU/mL) 0.05 (-0.003, 0.10) 0.02 (-0.02, 0.07) 0.05 (-0.004, 0.09) 0.12 (0.08, 0.17)4 0.09 (0.05, 0.14)4 0.14 (0.08, 0.20)4 





Table 3.3: Mean difference in log serum concentrations of reproductive hormones 
according to fructose-rich beverage intake (n=467 ovulatory cycles)1 
 
 Sweetened Soda 
≥ 1 vs < 1 cup/day 
Artificially Sweetened Soda 
≥ 1 vs < 1 cup/day 
Log 
Hormone Model 1
2 Model 12 Model 12 Model 2 3 
Total E2 
(ρg/mL) 0.12 (0.04, 0.21)
4 0.15 (0.06, 0.24)4 0.05 (-0.05, 0.15) 0.09 (-0.02, 0.19) 
Free E2  
(ρg/mL ) 0.12 (0.03, 0.21)




-0.02 (-0.23, 0.18) 0.02 (-0.22, 0.26) 0.03 (-0.19, 0.24) -0.02 (-0.26, 0.22) 
FSH  
(mIU/mL) -0.04 (-0.11, 0.02) 0.004 (-0.06, 0.07) 0.00 (-0.07, 0.07) 0.03 (-0.05, 0.11) 
LH (ng/mL) -0.01 (-0.11, 0.08) 0.07 (-0.03, 0.17) -0.004 (-0.11, 0.10) 0.05 (-0.06, 0.16) 
 Cola Soda 
≥ 1 vs < 1 cup/day 
Non-Cola Soda 
≥ 1 vs < 1 cup/day 
Log 
Hormone Model 1
2 Model 2 3 Model 12 Model 2 3 
Total E2 
(ρg/mL) 0.09 (0.01, 0.17)
 4 0.13 (0.05, 0.20) 4 0.09 (0.01, 0.17) 4 0.12 (0.04, 0.20) 4 
Free E2 
(ρg/mL ) 0.09 (0.01, 0.16)




-0.03 (-0.22, 0.15) -0.14 (-0.34, 0.07)  -0.03 (-0.22, 0.16) -0.14 (-0.35, 0.06) 
FSH  
(mIU/mL) 0.01 (-0.05, 0.07) 0.03 (-0.03, 0.09) 0.01 (-0.05, 0.07) 0.05 (-0.01, 0.11) 
LH (ng/mL) 0.04 (-0.04, 0.13) 0.10 (0.02, 0.19) 0.04 (-0.04, 0.13) 0.12 (0.04, 0.20) 
 Citrus Fruit Juice 
≥ 1 vs < 1 cup/day 
Non-citrus Fruit Juice 
≥ 1 vs < 1 cup/day 
Log 
Hormone Model 1
2 Model 2 3 Model 12 Model 2 3 
Total E2 
(ρg/mL) 0.05 (-0.06, 0.15) 0.04 (-0.04, 0.13) 0.04 (-0.05, 0.12) 0.09 (-0.03, 0.20) 
Free E2 




-0.19 (-0.46, 0.08) -0.14 (-0.36, 0.08) -0.17 (-0.37, 0.03) -0.09 (-0.42, 0.25) 
FSH  
(mIU/mL) 0.03 (-0.05, 0.10) 0.05 (-0.01, 0.12)
 0.03 (-0.04, 0.09) 0.07 (-0.02, 0.15) 
LH (ng/mL) 0.004 (-0.09, 0.09) 0.06 (-0.04, 0.15) -0.04 (-0.15, 0.08) 0.05 (-0.08, 0.18) 
E2, estradiol; FSH, follicle-stimulating hormone; LH, luteinizing hormone. 
1Anovulation is any cycle with peak progesterone concentration ≤ 5 ng/mL and no 
observed serum LH peak on the mid or late luteal phase visits (n=42 cycles). Beverage 
intake assessed at 4 times each cycle: menses, mid-follicular, ovulation and mid-luteal 






Table 3.3 continued 
 
2 Adjusted for age, waist-to-hip ratio, race, total energy intake, dietary quality score, and 
physical activity using linear mixed effects models on the log scale of hormones. Sodas 
additionally adjusted for total caffeine intake. 
3 Adjusted for age, waist-to-hip ratio, race, total energy intake, dietary quality score, 
physical activity, and relevant phase-specific hormone levels using weighted linear mixed 
effects models on the log scale of hormones with inverse probability of exposure weights. 






β=0.09 [95% CI: 0.03, 0.14]). No significant associations were found between 1-cup 
increments of artificially sweetened soda or juice intake and reproductive hormones. 
Nonlinear harmonic models mirrored the linear mixed models between added sugar, 
fructose, and sweetened soda intake and E2. Women who consumed ≥ 73.2 g/day of 
added sugar had elevated mean concentrations of free and total E2 concentrations (free 
E2: β=0.09 [95% CI: 0.02, 0.16]) in addition to increased amplitude for LH (β=0.13 [95% 
CI: 0.04, 0.21]) after adjusting for age, waist-to-hip ratio, race, total energy intake, 
dietary quality score, and physical activity (Figures 3.1-3.3). Similarly, women who 
consumed ≥ 41.5 g/day of fructose had a trend towards elevated free and total E2 (free 
E2: β=0.05[95% CI: -0.009, 0.11]), and increased amplitude for LH (β=0.06 [95% CI: -
0.03, 0.14]), but not statistically significant (Figure 3.1-3.3). In regard to beverage intake, 
women who consumed ≥ 1 cup/day of sweetened soda had elevated mean free and total 
E2 levels (free E2: β=0.14 [95% CI: 0.02, 0.26]) after multivariate adjustment (Figure 
3.4).  
Anovulation 
No significant associations were found between intake of added sugar (≥40.0 
g/day versus <40.0 g/day or ≥73.2 g/day versus <73.2 g/day), fructose (≥41.5 g/day 
versus <41.5 g/day), soda, or juice intake (≥1 cup/day vs <1 cup/day) and ovulatory 
function (Table 3.4). Sensitivity analyses for 1-cup increments of beverage consumption 
yielded no statistically significant results nor did assessing anovulation based on the less 
conservative definition (peak progesterone ≤ 5 ng/mL). 
 
  
Figure 3.1: Adjusted mean serum total E2 concentrations across the menstrual cycle according to added sugar (≥73.2 g/day vs. 
less; usual intake for American women) and fructose intake (≥41.5 g/day vs. less; 66th percentile) based on nonlinear harmonic 



















































































Figure 3.2: Adjusted mean serum free E2 concentrations across the menstrual cycle according to added sugar (≥73.2 g/day vs. 
less; usual intake for American women) and fructose intake (≥41.5 g/day vs. less; 66th percentile) based on nonlinear harmonic 































































Figure 3.3: Adjusted mean serum LH concentrations across the menstrual cycle according to added sugar (≥73.2 g/day vs. less; 
Usual intake for American women) and fructose intake (≥41.5 g/day vs. less; 66th percentile) based on nonlinear harmonic 









































Figure 3.4: Adjusted mean serum total and free E2 concentrations across the menstrual cycle according to sweetened 









































































Table 3.4: Odds of anovulation1 with consumption of  added sugar, fructose and fructose-rich beverages2 
 
   Multivariate adjusted OR (95% CI)3 
Nutrient Intake    
Added Sugar (AHA recommended limit)6 ≥ 40 vs < 40 g/day 0.94 (0.53, 1.64) 
Added Sugar ≥ 73.2 vs < 73.2 g/day 0.73 (0.37, 1,43) 
Fructose ≥ 41.5 vs < 41.5 g/day 0.74 (0.39, 1.40) 
 
Beverage Intake    
Sweetened Soda ≥ 1 vs < 1 cup/day 1.29 (0.53, 3.14) 
Artificially Sweetened Soda ≥ 1 vs < 1 cup/day 1.10 (0.35, 3.47) 
Cola Soda ≥ 1 vs < 1 cup/day 1.00 (0.29, 1.98) 
Non-Cola Soda ≥ 1 vs < 1 cup/day 0.76 (0.29, 1.97) 
Citrus Fruit Juice ≥ 1 vs < 1 cup/day 0.79 (0.34, 1.83) 
Non-citrus Fruit Juice ≥ 1 vs < 1 cup/day 0.67 (0.25, 1.84) 
 
1Anovulation is any cycle with peak progesterone concentration ≤ 5 ng/mL and no observed serum LH peak on the mid or late luteal 
phase visits (n=42 cycles).  
2 Intake assessed at 4 times each cycle: menses, mid-follicular, ovulation and mid-luteal clinic visits via 24-hour dietary recall. 
Fructose equal to the intake of free fructose plus half the intake of sucrose. 
3Adjusted for age, waist-to-hip ratio, race, total energy intake, dietary quality score, and physical activity using generalized linear 






 We observed that while added sugar intake above the recommended AHA levels 
was not associated with reproductive hormone levels, those who consumed above the 
average intake for American women for added sugars (≥73.2 g/day) or above the 66th 
percentile for fructose (≥ 41.5 g/day) had elevated free E2, FSH, and LH concentrations 
compared to women who consumed less. Sweetened soda intake (≥1 cup/day versus < 1 
cup/day) was associated with elevated free and total E2 but no statistically significant 
associations between artificially sweetened soda and fruit juice and reproductive 
hormones were found. Fructose and fructose-rich beverages were not associated with 
sporadic anovulation among the BioCycle participants. Findings from this study suggest 
that intakes greater than typical levels among American women of added sugars, fructose 
and sweetened sodas may increase serum levels of reproductive hormones but do not 
interfere with ovulation among healthy premenopausal women with no known ovulatory 
disorders.  Following the AHA guidelines for dietary added sugars appears to be prudent 
if elevated reproductive hormone concentrations are of concern. 
 Our finding that added sugar, total fructose, and sweetened soda consumption was 
significantly and positively associated with reproductive hormone concentrations after 
multivariable adjustment is novel in humans. While we are aware of no previous animal 
or human studies investigating the relationship between E2, progesterone, FSH, or LH, 
and fructose or added sugar, our results showing increased E2 concentrations with 
sweetened soda intake mirror results from animal studies (36). Celec et al. found intake 
of 3 different sweetened cola drinks to be associated with increased E2 levels in adult 




reproductive hormone levels in humans found null associations (14, 15). In particular, 
Lucero et al. found no association between ≥ 1 cup/day of caffeinated cola intake with 
geometric mean levels of early follicular phase FSH, LH, total E2 or SHBG 
concentrations in a study of 498 predominately (97%) white women ages 36 to 45 (15) 
while Nagata et al. found no significant association between cola and follicular or luteal 
E2 among Asian college women (n=50) in Japan (14). Comparing Lucero’s and Nagata’s 
studies with ours is limited since their assessment of diet was retrospective and their 
hormone measurement included at most 2 serum samples over 1 menstrual cycle, while 
we assessed diet prospectively and obtained up to 16 serum samples over 2 menstrual 
cycles using a validated method to time cycle phase (19). Finally, we assessed both cola 
and noncola sodas. While caramel coloring in cola sodas (which contains advanced 
glycation end products) has been associated with adverse health effects in animal models 
(25), we found no distinction in the relationship between cola and noncola sodas with 
reproductive hormones, indicating that this is not a component of concern regarding 
reproductive health. Alternatively, given that BioCycle Study participants consumed less 
cola soda than average US populations, their consumption of such beverages may have 
been too low to detect any differences between cola and noncola sodas. 
 While limited data exist on the effect of fructose and sweetened soda on 
reproductive hormones, other studies have demonstrated that sweetened beverages are 
associated with impaired fasting glucose and metabolic syndrome (37, 38). Since sucrose 
and high fructose corn syrup (HFCS) are both composed of roughly equal parts glucose 
and sucrose, many believe that the effects on the endocrine system are equivalent (1). 




effect of sucrose-sweetened beverages or fructose-rich beverages (e.g., fruit juice) (38), 
due to the reactive carbonyls found in drinks containing HFCS (39). While we could not 
distinguish between sodas sweetened with sucrose from those sweetened with HFCS, our 
results showing elevated reproductive hormone concentrations with added sugars, total 
fructose, and a variety of sweetened beverages (including an elevated trend with fruit 
juice) support the hypothesis that the effects of fructose do not differ between sucrose- or  
HFCS-sweetened beverages.  
 The question remains, however, as to whether fructose or some other component 
in sweetened beverages is associated with elevated E2 concentrations. Including fructose 
intake in our multivariate models with beverages made the relationship between 
sweetened soda, fruit juice intake, and E2 weaker, suggesting that fructose explains part 
of the association. While fructose may contribute, the trend towards elevated E2 with 
artificially sweetened soda intake ≥ 1 cup/day suggests that additional components may 
be at work. Other studies have found that sodas (regardless of sugar content) contribute to 
adverse health effects, (13, 40) including a recent study by Chavarro et al. that found an 
increased risk of ovulatory disorder infertility among premenopausal women in the 
Nurses’ Health Study for both sweetened and artificially sweetened soda (13). The theory 
that soda (irrespective of sugar content) may be replacing a nutrient or food component in 
the diet, and that it is the lack of this component causing the effect is well documented in 
the literature (41). Individuals who consume soda are known to also have greater caloric 
and fat intake (42), and a more sedentary lifestyle (43). Soda consumers in the BioCycle 
Study were more likely to have a higher waist-to-hip ratio, a lower percent of calories 




adiposity as well as total energy intake, we found no statistically significant associations 
between artificially sweetened soda and reproductive hormones; however, the 
associations we observed between added sugar, fructose, and sweetened sodas remained. 
While residual confounding by either lifestyle or socio-economic factors may persist, our 
well-measured prospective assessment of diet and physical activity may explain why we, 
as well as others (44), have found differing effects between sweetened and artificially 
sweetened sodas compared to others who have not (13, 40). Additionally, although fruit 
juices are a known contributor to fructose intake, our finding of a statistically significant 
association between sweetened soda and reproductive hormone concentrations, but not 
fruit juice, may be due to the beneficial components of fruit juice including vitamins and 
antioxidants (44), which are often lacking in consumers of sugar-sweetened beverages 
(45). Further research looking at the relationship between different juice types (including 
freshness and processing (44)) and premenopausal reproductive hormones is needed. 
The BioCycle Study has several strengths, including multiple measures of 
hormone assessment over 2 menstrual cycles (using standardized methods to time cycle 
phase) and multiple measures of not only fructose and fructose-rich beverage intake, but 
important dietary and lifestyle factors as well. While self-report of diet is subject to 
measurement error (46-48), our study used multiple validated 24HDRs to reduce the 
potential for misclassification in added sugar, fructose and beverage exposure. 
Additionally, we assessed recall validity by comparing total soda intake with the averages 
obtained from 2 food frequency questionnaires captured over the same time period and 
found significant correlation (r=0.70). Nevertheless, the study was limited by the 




consume on average 78 g/day of added sugar, 19 oz of soda, and 3 oz of fruit juice (2) 
whereas the BioCycle Study participants consumed on average 57.2 g/day of added 
sugars, 3 oz of soda, and 4 oz of fruit juice. 
In conclusion, mean intake of added sugars greater than the intake of the average 
American woman (≥ 73.2 grams/day), fructose ≥ 41.5 g/day, and sweetened soda ≥ 1 
cup/day are associated with elevated E2 concentrations. While we observed no effect on 
incident anovulation with moderate sweetened beverage consumption, further research 
investigating higher consumption (i.e., around the US female average of  ≥  2 8-oz 
servings/day), along with inclusion of women with more pronounced ovulatory disorders 
is warranted (13). Since a randomized trial investigating the effects of soda on 
reproductive function may not be feasible, further methodologically rigorous 
observational studies using gold-standard measures of exposure assessment are needed to 
better understand the effects of fructose on reproductive hormone levels and ovulatory 
function. While recent research indicates that consumption of added sugars is decreasing 
in the Unites States (49), mean intakes among premenopausal women continue to exceed 
recommendations. Our findings have public health implications not only for the role that 
fructose and fructose-rich beverages have on female fertility, but also for their potential 
relationships with a woman’s future risk for chronic diseases associated with 
reproductive hormones. 
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CHAPTER 4 
CAFFEINE VALIDATION USING DIFFERENT INSTRUMENTS  
IN THE BIOCYCLE STUDY 
Abstract 
The effects of caffeine on women’s health are inconclusive due in part to 
inadequate exposure assessment. We determined validity of a food frequency 
questionnaire (FFQ) for measuring monthly caffeine and caffeinated beverage intake 
compared to multiple 24-hour dietary recalls (24HDR); and validity of the 24HDR for 
measuring daily caffeinated coffee intake compared to prior days’ diary record. The 
BioCycle Study (2005-2007)  prospective cohort (n=259) included women, ages 18-44, 
who were followed for 2 menstrual cycles, completing up to 4 24HDRs per cycle, an 
FFQ at the end of each cycle, and daily diaries. Caffeine was analyzed using the Nutrition 
Data System for Research (2005) for the FFQ and 24HDR. We determined validity of 
mean caffeine and caffeinated beverage intake from the FFQs compared to the 24HDRs 
via Wilcoxon’s matched-pairs, signed-ranks tests and Pearson’s correlation coefficients. 
We assessed agreement via cross-classification analyses and kappa statistics. Repeated 
measures analyses evaluated validity of the 24HDR compared to the daily diary. Caffeine 
intake reported in the FFQ was greater than that reported in the 24HDRs (mean=114.1 
versus 92.6 mg/day; P=0.006) despite high correlation (r=0.80, P< 0.001) and moderate 




caffeinated coffee intake in their daily diary compared to their corresponding 24HDR 
(mean=0.80 versus 0.51 cups/day, P< 0.001). Although caffeine and coffee exposures 
were highly correlated, absolute intakes differed significantly between measurement 
tools. These results highlight the importance of considering potential misclassification of 
caffeine exposure. Further validation with biomarker assessment is needed. 
Introduction 
Caffeine, the most widely consumed drug in the world (1), is ingested primarily 
through coffee, tea, and soda  and has received a great deal of attention regarding its 
health effects on premenopausal women (2, 3). Coffee, tea, and soda contain other 
components in addition to caffeine that may affect health, highlighting the importance of 
beverage source (4, 5). Health effects of caffeine and caffeinated beverages have been 
inconclusive due in part to inadequate exposure assessment (2, 3). 
Measuring caffeine intake is difficult since it occurs in a variety of sources (6). 
Additionally, caffeine exposure can vary depending on brand, serving size, and method 
of preparation (7). Retrospective assessment of caffeine at a single time point may be 
prone to measurement error since it fails to account for exposure fluctuations (2) and 
prospective assessment may lack precision if it fails to capture the caffeine content of 
different foods and beverages (8). Caffeine exposure misclassification may bias effect 
estimates towards or away from the null depending on the magnitude and direction of the 
errors (2). Therefore, it is important to determine the validity of common methods of 
measuring caffeine consumption among reproductive-aged women. 
Most studies assessing caffeine among nonpregnant, premenopausal women use 




records and recalls are generally considered to be the gold standard for dietary 
assessment, and thus are often used as the reference when assessing the relationship 
between reported intakes from an FFQ and true usual intake (13). Various versions of the 
FFQ have been validated for caffeine intake among non-American, older women in 2 
previous studies (mean age: 54 and 58 years) (13, 14); and for caffeinated beverages (i.e., 
coffee, tea, and soda) among pre- to perimenopausal American women (ages 34-59, 
uniformly distributed) (15). No study to date, however, has investigated the validity of an 
FFQ for both caffeine and caffeinated beverage intake (caffeine/beverage intake) for 
American reproductive-age women using appropriate statistical methods. Validation 
studies depending on correlation analyses alone are inadequate since correlation measures 
the strength of the linear relationship, not agreement, and correlations depend on the 
range of the true quantity within the sample (16).  
Our primary objective was to assess the validity of 1) the FFQ for measuring 
monthly caffeine/beverage intake compared to multiple 24-hour dietary recalls (24HDRs) 
and 2) the 24HDR for measuring daily caffeinated coffee intake compared to daily diary 
(DD) records. Our secondary objective was to assess the variability of caffeine 
consumption patterns by comparing 1) caffeine/beverage intake for 8 24HDRs and (for 
caffeinated coffee) DDs, captured over 2 menstrual cycles, and 2) caffeine/beverage 
intake for the FFQ completed at baseline (capturing the previous 6 month’s intake) with 





Subjects and Methods 
Study Population 
Women, ages 18-44, were recruited between 2005-2007 from western New York 
State and enrolled for 1 (n=9) or 2 (n=250) menstrual cycles in the BioCycle Study. The 
study population, materials and methods have been previously described in detail (17). In 
summary, eligible women had to be healthy, with self-reported cycle length from 21-35 
days for the previous 6 months, no use of hormonal contraception for the past 3 months, 
and without known conditions that affect the menstrual cycle, such as polycystic ovary 
syndrome or uterine fibroids. Physical measures were obtained in the clinic using 
standardized protocols and socio-demographic and lifestyle information was collected 
using validated questionnaires (17). The University at Buffalo Health Sciences 
Institutional Review Board (IRB) approved the study and served as the IRB designated 
by the National Institutes of Health for this study under a reliance agreement. All 
participants provided written informed consent. 
Dietary Assessment  
Food Frequency Questionnaire (FFQ)  
 Participants completed an FFQ up to 3 times at the clinic; once at baseline (FFQ-
B) to capture usual intake for the previous 6 months and during the late luteal phase of 
each cycle to determine usual intake in the month of each cycle (FFQ-1 and FFQ-2). 
Nutrient data were collected using the FFQ developed by the Nutrition Assessment 
Shared Resource (NASR) of the Fred Hutchinson Cancer Research Center (FHCRC), 
which calculated nutrient intakes using the Nutrition Data System for Research (NDSR) 




Minnesota, Minneapolis, MN. NDSR uses the standardized, multiple-pass approach of 
interview methodology, and computes the nutrients (e.g., caffeine in mg/day) and the 
food/beverage components (e.g., unsweetened coffee in cups/day) from the assessments. 
The NDSR calculates caffeine intake based on consumption-weighted averages of values 
provided by the USDA database. The BioCycle Study used the general FFQ (GSEL). 
This self-administered FFQ asks participants to report on the frequency of consumption 
(e.g., never or less than once per month to 6+ per day) and portion size (e.g., small, 
medium, or large with medium size described) of approximately 120 line items, including 
5 caffeinated beverages. Ninety-nine percent of the participants completed at least 1 of 
the FFQs, while 86% completed all 3 FFQs (FFQ-B, FFQ-1, and FFQ-2). 
24-Hour Dietary Recall (24HDR)  
Participants completed a 24HDR at the clinic after fasting blood specimen 
collection during the visits corresponding to menstruation, mid-follicular phase, 
ovulation, and mid-luteal phase. Information regarding food and beverage intake was 
collected and nutrient data were analyzed using NDSR (version 2005). Seventy-three 
percent of participants completed all 8 24HDRs, 96% completed 4 24HDRs in at least 1 
of their cycles under study, while 99% completed at least 3 24HDRs per cycle (i.e., 249 
out of the 250 women contributing 2 cycles completed at least 3 24HDRs in both of their 





Daily Diary (DD) 
Participants recorded daily caffeinated coffee intake and other lifestyle/health 
items on DD forms. Study staff instructed participants to begin completing their DD on 
the first day of their next menstrual period and continue daily through the next 2 
menstrual cycles. Participants recorded the number of 8 oz cups (hot or iced/instant or 
brewed) of caffeinated coffee consumed daily. Ninety-seven percent of participants 
completed at least 75% of the DDs in at least 1 of their cycles; 71% of participants 
completed 100% (i.e., no missed days) in at least 1 of their cycles. 
Statistical Analysis 
Validity of Caffeine/Beverage Intake  
Descriptive statistics were calculated including socio-demographic characteristics.  
Caffeine/beverage intake from the 24HDRs and FFQs were non-normally distributed and 
therefore nonparametric analysis techniques were used. To determine the validity of the 
FFQ compared to the 24HDR, women who completed either the FFQ-1 or FFQ-2 and at 
least 75% of their 24HDRs for the corresponding cycle were included in the analyses 
(n=249). To validate the DD compared to the 24HDR, women who completed at least 
75% of their 24HDRs and DDs in at least 1 of their cycles (n=251) were included.  
To evaluate validity of the FFQ for assessing monthly caffeine/beverage intake, 
we compared the mean value of FFQ-1 and FFQ-2 with the mean value of the 8 24HDRs. 
We additionally compared the 4 24HDRs per cycle with their corresponding FFQ. We 
report means and standard deviations (SD) along with medians and interquartile ranges 




Wilcoxon’s matched-pairs signed-ranks test to determine differences between the means. 
Pearson’s correlation coefficients on log-transformed values described the associations 
between the FFQs and 24HDRs. We also calculated deattenuated Pearson’s correlation 
coefficients where the within-woman variations were divided by the between-woman 
variations to quantify the variance ratios of the 24HDRs (18).  
To visualize agreement between the FFQ and 24HDR for caffeine/beverage 
intake, we constructed Bland and Altman plots using the mean value of FFQ-1 and FFQ-
2 and the 8 24HDRs. We present the plots on the original scale with back-transformed 
limits of agreement (LA) (19). To evaluate the FFQ’s ability to assign women to the same 
categories of intake as the 24HDR, women were classified into tertile categories of 
caffeine/beverage intake based on the distribution of data from both the FFQ and 24HDR 
(20, 21). Due to the highly skewed data for coffee drinks/cocoa, cut points at the 10th and 
90th percentile were used to create the categories for coffee drinks/cocoa. We performed 
cross-classification analyses and compared percent agreement and weighted κ 
coefficients calculated with a linear set of weights in addition to calculating actual values 
for surrogate tertiles of caffeine/beverage intake (cutpoints of 10th and 90th percentile for 
coffee drinks/cocoa) with the FFQ and the 24HDR as the surrogate and reference method, 
respectively (20). We used recommended levels of daily caffeine intake (preconception 
counseling: ≤200 mg/day) (22) as the threshold value to estimate specificity, sensitivity, 
and positive and negative predictive values of the FFQ, whereby intakes in line with the 
recommended levels were defined as positive.  
To evaluate validity of the 24HDR for assessing daily caffeinated coffee intake, 




previous day’s DD. We chose a relevant cut point ( ≥ 1 cup/day versus < 1cup/day) (12) 
to estimate specificity, sensitivity, and positive and negative predictive values of the 
24HDR. 
Variability of Caffeine/Beverage Intake  
To determine whether there was a habitual pattern of caffeine/beverage intake 
over the study period as reported in the FFQ, we repeated the above analyses to assess the 
agreement between FFQ-1 and FFQ-2 (with the exception of de-attenuating the 
correlation coefficients, deemed unnecessary for reproducibility studies) (20), restricting 
to women who completed both FFQ-1 and FFQ-2 (n=224). We compared FFQ-B with 
the mean of FFQ-1 and FFQ-2, to account for changes in consumption while under 
observation, restricting to women who completed all 3 FFQs (n=222). 
To determine habitual pattern of caffeine/beverage intake as reported in the 
24HDRs, we used repeated measures analyses with random intercepts, restricting to 
women who completed at least 75% of their 24HDRs for a given cycle (n=258). These 
models accounted for between-woman variation in baseline caffeine intake and within-
woman correlation. P values correspond to 2-sided tests with significance set at 0.05. 
Analyses were performed in SAS version 9.2 (SAS Institute, Cary, NC).  
Results 
Population Characteristics 
The mean age of participants included in the primary validity study (n=249) was 
27.5 (SD=8.3).  Participants were of normal weight (mean BMI of 24.1 (SD=3.8)), 




as recorded in their daily diaries) (95.6%), and nulligravidous (69.1%).  Demographics of 
women included in variability analyses as assessed by the FFQ (n=224) were similar to 
the validity study.  
Validity of Caffeine/Beverage Intake 
  According to FFQ-B, 58% reported consuming coffee, 72% tea, 64% lattes, 
cappuccinos, mochas, or hot chocolate (coffee drinks/cocoa), and 77% soda. Similar 
patterns were seen for the FFQ-1 and FFQ-2, with 60% consuming coffee, 72% tea, 65% 
coffee drinks/cocoa, and 80% soda. Average 24HDR beverage consumption was less 
than that reported by FFQs, with 49% consuming coffee, 64% tea, 21% coffee 
drinks/cocoa, and 71% soda.  
Compared to the 24HDR, the FFQ significantly overestimated usual daily 
caffeine (mean=114.1 versus 92.6 mg/day; geometric mean=48.9 versus 41.4; P=0.005), 
coffee (mean=0.76 versus 0.51 cups/day; geometric mean=0.11 versus 0.08; P<0.001), 
and coffee drinks/cocoa intake (mean=0.18 versus 0.09 cups/day; geometric mean=0.05 
versus 0.02; P<0.001); and underestimated usual daily soda intake (mean=0.41 versus 
0.57 cups/day; geometric mean=0.12 versus 0.16; P<0.001), although the log-
transformed caffeine/beverage intakes were all significantly correlated (P<0.001) (Table 
4.1). Despite divergence, the Bland-Altman plots showed acceptable relative limits of 
agreement (Figure 4.1). The intrawoman LA were ± 1.14 for caffeine, ± 0.94 for coffee, ± 
1.34 for coffee drinks/cocoa, ± 1.45 for tea, and ± 1.24 for soda. Differences for all 
beverages followed a normal distribution except for coffee. Results were similar when we 
compared the average of the 24HDRs per cycle with the corresponding FFQ (data not 
shown). 
  
Table 4.1: Usual daily intakes of caffeine and caffeine-related beverages calculated from the FFQ and 24HDR (n=249); 
differences and correlation coefficients between the mean FFQ (test method) and 24HDR (reference method)1 
 FFQ 24HDR P 2 Correlation
 Mean ± SD Median (IQR) Mean ± SD Median (IQR)  R3 R4 
Caffeine 
(mg/day) 114.1 ± 146.1 68.1 (19.5-147.5) 92.6 ± 95.1 59.8 (19.4-140.8) 0.006 0.68 0.73 
Coffee 




0.81 ± 0.50 0.05 (0.00-0.15) 0.09 ± 0.33 0.00 (0.00-0.00) <0.001 0.39 0.40 
Tea 
(cups/day) 0.38 ± 0.75 0.09 (0.00-0.39) 0.36 ± 0.49 0.17 (0.00-0.50) 0.38 0.57 0.59 
Soda 
(cups/day) 0.41 ± 0.68 0.12 (0.03-0.42) 0.57 ± 0.71 0.31 (0.00-0.80) <0.001 0.68 0.71 
 
1 24HDR, 24-hour dietary recall, average of 8 24HDRs over 2 cycles; FFQ, food-frequency questionnaire, average of FFQ1 and FFQ2 
over 2 cycles. Coffee is all types “not lattes or mochas”; coffee drinks/cocoa includes “latte, cappuccino, mocha or hot chocolate”; 
“tea is “all types”; and soda includes diet and regular soft drinks. 
2 Wilcoxon’s matched-pairs signed-rank test 
3 Pearson’s correlation coefficient on log-transformed data. All correlations significant at P<0.001. 
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Figure 4.1: Bland-Altman plots of difference in caffeine (mgs/day) and beverage  
(cups/day) intakes between the FFQ and 24HDR. Dotted line in each graph 
represents mean difference between FFQ and 24HDR on original scale; solid lines 




The majority (55–79%) of women were assigned to the same tertiles by both 
methods except for coffee drinks/cocoa where the majority of women (49%) were 
assigned to the adjacent, 45% to the same, and 6% to the extreme category (Table 4.2). 
Weighted κ values showed substantial agreement for coffee; moderate agreement for 
caffeine, soda, and tea; and slight agreement for coffee drinks/cocoa.  Actual values for 
surrogate tertiles of usual daily caffeinated beverage intake are shown in Table 4.3.  
Using recommended daily amounts for caffeine as the threshold value (<200mg/day), 
sensitivity of the FFQ was 0.90 while specificity was 0.79. The positive and negative 
predictive values were 0.97 and 0.56. 
Despite high correlation (Pearson’s correlation coefficient on log-transformed 
data=0.77, P<0.001), women reported significantly less caffeinated coffee intake in the 
24HDR compared to the corresponding day’s DD (mean=0.51 versus 0.80 cups/day; 
geometric mean=0.05 versus 0.08; P< 0.001) (Figure 4.2).  Mean differences between the 
24HDR and the DD were similar for both cycles. 
Variability of Caffeine/Beverage Intake 
Mean daily intakes of caffeine and caffeinated beverages for FFQ-1 and FFQ-2 
were highly correlated (0.72 to 0.94) as were intakes for FFQ-B and FFQ-1&2 (0.76 to 
0.94) (Table 4.4). While no statistically significant differences were found in mean daily 
intakes between FFQ-1 and FFQ-2, coffee intake was lower in FFQ-B compared with 
FFQ-1&2 (mean=0.69 to 0.77 cups/day, geometric mean=0.10 versus 0.11; P=0.02) 
while tea intake was higher in FFQ-B (0.47 to 0.38 cups/day; geometric mean=0.10 
versus 0.09; P=0.04). Cross-classification between FFQ-1 and FFQ-2 showed little severe 
misclassification and substantial agreement for caffeine, coffee, and soda tertiles 
  
Table 4.2: Cross-classification and κ coefficient of the FFQ and 24HDR tertiles1 of daily caffeine, coffee, coffee drinks/cocoa, 
tea and soda intakes (n=249 women) 





n (%) Weighted κ (95% CI) 
Caffeine (mg/day) 159 (64) 80 (32) 10 (0.04) 0.55 (0.47, 0.64) 
Coffee (cups/day) 196 (79) 50 (20) 3 (0.01) 0.76 (0.70, 0.82) 
Coffee drinks/cocoa 
(cups/day) 111 (45) 123 (49) 15 (6) 0.20 (0.12, 0.27) 
Tea (cups/day) 136 (55) 95 (38) 18 (7) 0.41 (0.31, 0.50) 
Soda (cups/day) 153 (61) 86 (35) 10 (4) 0.51 (0.43, 0.60) 
 
1Due to the highly skewed data for coffee drinks/cocoa, cut points were at 10th and 90th percentiles. 
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Table 4.3: Actual values for surrogate tertiles1 of usual daily caffeine, coffee, coffee drinks/cocoa, tea and soda intake with the 
FFQs and the 24HDRs as the surrogate and reference method, respectively 
 
 1st tertile 
Mean ± SD 
2nd tertile 
Mean ± SD 
3rd tertile 
Mean ± SD P
2 
Caffeine (mg/day) 36.2 ± 46.9 68.9 ± 50.2 190.7 ± 101.8 <0.001 
Coffee (cups/day) 0.0 ± 0.1 0.2 ± 0.3 1.4 ± 0.7 <0.001 
Coffee drinks/cocoa 
(cups/day) 0.0 ± 0.1 0.1 ± 0.4 0.3 ± 0.4 <0.001 
Tea (cups/day) 0.2 ± 0.3 0.3 ± 0.4 0.6 ± 0.6 <0.001 
Soda (cups/day) 0.2 ± 0.3 0.4 ±  0.4 1.2 ± 0.8 <0.001 
 
1Due to the highly skewed data for coffee drinks/cocoa, cut points were at 10th and 90th percentiles. 
2Kruskal-Wallis test  
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Figure 4.2: Usual daily intakes of cups of caffeinated coffee calculated from the 24HDR and DD, (n=258 women) comparing 
caffeinated coffee intake reported in the diary on the day preceding the clinic visit and with that reported in the 24HDR at the 




Table 4.4: Usual daily intakes of caffeine and caffeinated beverages calculated from FFQ; differences and correlation 
coefficients between FFQs1  
 FFQ-1 FFQ-2 P2 Correlation  Mean ± SD Median (IQR) Mean ± SD Median (IQR) R3
Caffeine (mg/day) 112.6 ± 130.8 68.7 (16.4-157.2) 114.5 ± 136.3 71.5 (15.6-153.0) 0.92 0.86 




0.15 ± 0.32 0.06 (0.00-0.14) 0.15 ± 0.39 0.02 (0.00-0.14) 0.48 0.72 
Tea (cups/day) 0.39 ± 0.79 0.06 (0.00-0.39) 0.37 ± 0.84 0.06 (0.00-0.39) 0.10 0.76 
Soda (cups/day) 0.42 ± 0.78 0.12 (0.03-0.39) 0.41 ± 0.74 0.12 (0.03-0.39) 0.86 0.84 
 FFQ-B FFQ-1&2 P2 Correlation  Mean ± SD Median (IQR) Mean ± SD Median (IQR) R3 
Caffeine (mg/day) 114.5 ± 140.4 71.8 (20.6-150.8) 113.4 ± 128.6 70.9 (17.6-152.1) 0.66 0.86 




0.19 ± 0.59 0.06 (0.00-0.14) 0.15 ± 0.32 0.03 (0.00-0.14) 0.15 0.79 
Tea (cups/day) 0.47 ± 1.01 0.09 (0.00-0.39) 0.38 ± 0.76 0.09 (0.00-0.39) 0.04 0.76 
Soda (cups/day) 0.46 ± 0.82 0.14 (0.03-0.39) 0.41 ± 0.69 0.12 (0.03-0.45) 0.30 0.82 
 
1FFQ-1, food-frequency questionnaire captured at end of cycle 1; FFQ-2, food-frequency questionnaire captured at end of cycle 2; 
FFQ-B, food-frequency questionnaire captured at baseline, FFQ-1&2, average of FFQ-1 and FFQ-2 over 2 cycles. n=224 women for 
comparison between FFQ-1 and FFQ-2; n=222 women for comparison between FFQ-B and FFQ-1&2. 
2 Wilcoxon’s matched-pairs signed-rank test. 





(weighted κ =0.80, 0.86, 0.71, respectively) (Table 4.5). Coffee drinks/cocoa (κ =0.58) 
and tea (κ =0.61) showed moderate agreement. Similar levels of agreement were found 
between FFQ-B and FFQ-1&2.  
Neither caffeine nor caffeinated beverage intake as measured by the 24HDR 
varied significantly over the 2 menstrual cycles (Figure 4.3).  Caffeine consumption 
reported in the DD was also consistent across the cycle (Figure 4.3). 
Discussion 
We show that although caffeine and caffeinated beverage intake are highly 
correlated between measurement tools in the BioCycle Study, absolute intakes differed 
significantly. While the FFQ is appropriate for ranking caffeine and caffeinated beverage 
exposure, it may not appropriately classify exposure based on clinically relevant cut 
points. As such cut points are used to guide policy decisions; our findings have broad 
public health implications. We demonstrate that the FFQ reported caffeine intake was 
consistent over the 2 menstrual cycles under study; or from the consumption over the 
previous 6 months, as reported at baseline, to that while under observation. Our analysis 
of 24HDR and DD reported caffeine/beverage intakes further support that caffeine intake 
was habitual and relatively consistent over the course of the menstrual cycle.  FFQ and 
24HDR reported caffeine/beverage intakes were more highly correlated than previous 
validation studies.  Prior population-based studies of women demonstrated deattenuated 
correlations between 0.64 to 0.76 (13-15 , 23). Given that correlations above 0.50 
between a dietary instrument (such as the FFQ) and a reference method (such as a dietary 
record or 24HDR) indicate that the instrument can reliably rank persons (20), both our 
and previous studies support the FFQ as a valid instrument to rank intake. The FFQ’s 
  
Table 4.5: Cross-classification and κ coefficient of the FFQ-1  and FFQ-2 tertiles of daily caffeine and caffeinated 
beverage intakes (n=224 women). 





n (%) Weighted κ (95% CI) 
Caffeine (mg/day) 177 (79) 37 (17)  10 (4) 0.80 (0.73-0.86) 
Coffee (cups/day) 194 (87) 30 (13) 0 (0) 0.86 (0.81-0.91) 
Coffee drinks/cocoa 
(cups/day) 151 (67) 52 (23) 21 (9) 0.58 (0.48-0.66) 
Tea (cups/day) 155 (69) 58 (26) 11 (5) 0.61 (0.53-0.69) 












ability to rank individuals for caffeinated beverages is not surprising as participants more 
easily report frequently consumed foods and beverages (20). 
While adequate ranking of individuals may be sufficient for many 
epidemiological analyses (14, 15), assessments of absolute intakes are necessary for 
formulating recommended levels of consumption and comparability between studies (15). 
We found that mean caffeine intake reported in the 24HDRs was lower than that reported 
in the FFQs over the same time period. Our findings agree with comparisons between a 
dietary record and the FFQ in the Nurses’ Health Study for coffee intake (1.8 versus 2.4 
cups/day, respectively) (15); but other studies reported higher mean caffeine intake in the 
7-day diet record compared to the FFQ (206 versus 143 mg/day) (14), or roughly 
equivalent caffeine intake between 3 24HDRs and an FFQ corresponding to the same 
time period (218 versus 216 mg/day)(13).The difference in reported intake between the 
24HDR and FFQ could be due to daily variation in consumption patterns. The majority 
(93%) of 24HDRs in our study occurred on weekdays and, among this population of 
women, caffeine intake may occur more frequently on weekends, particularly since 
caffeine and alcohol intake were associated in the BioCycle Study and alcohol 
consumption is higher on the weekends. Over the 2 menstrual cycles, mean caffeinated 
coffee intake reported in the DD was equivalent to mean coffee intake reported in the 
FFQ, suggesting that the 24HDRs may have missed higher coffee consumption days.   
The difference in absolute intakes between the FFQ, 24HDR, and the DD may be 
attributable to the tendency to over-report socially desirable foods and beverages and 
under-report less healthy foods (15). The standardized, multipass method of a 24HDR 




participants were instructed to report total number of cups of caffeinated coffee 
consumed in their DD, rounding up of caffeinated coffee intake may have occurred. 
Coffee has been publicized to contain antioxidants and chemo-preventive properties, 
which could account for the statistically significant higher report of coffee intake. 
Negative reports on soda may explain our finding a significantly lower reported 
consumption in the FFQ compared to the 24HDR. 
Classification analyses for caffeine have been conducted in 1 other study with 
nearly identical results (weighted κ =0.64), despite a difference in mean caffeine intake in 
the FFQ between their study (143 ± 105mg) and our study (114 ± 128mg) (14). We found 
that the FFQ reliably distinguished extreme caffeine intake as documented previously 
(14). No other studies have assessed actual values for surrogate categories nor looked at 
the sensitivity, specificity, and positive and negative predictors of the FFQ for caffeine 
intake based on recommended limits of intake. Use of actual values obtained from the 
24HDR for the surrogate categories derived from the FFQ in our study indicated that 
variation between-women for caffeine and caffeinated beverages is relatively high 
compared to the relatively low within-woman variation. In terms of how well the FFQ 
can “screen” women based on recommended levels of intake (22), if we assume that the 
24HDR accurately assessed intake, use of the FFQ would wrongly categorize 3% of 
women below recommended levels and 8% of women above recommended levels.  
The FFQ showed that caffeine/beverage intake did not significantly vary for 
BioCycle Study participants, both between the baseline and study period values (maximal 
misclassification was 4% for tea) as well as over the course of the study (maximal 




intake among the BioCycle Study participants is neither prone to month-to-month 
variability nor influenced by enrollment in the study. 
Ours is the first study to investigate the validity of the FFQ for reporting of coffee 
drinks/cocoa. Analyses of specific foods or beverages (e.g., coffee drinks), instead of 
nutrients (e.g., caffeine), are useful for detecting questionnaire weaknesses and potential 
modifications (15).  Average coffee drinks/cocoa intake between the FFQ and 24HDR 
were weakly correlated, possibly indicating that the FFQ poorly measures these 
beverages, as multiple beverages are collapsed into 1 category and showed low between-
person variability. If the research aim is to assess caffeine intake, this category should be 
divided into drinks containing espresso (including number of shots) versus cocoa, given 
the difference in caffeine content between espresso and chocolate. Such a questionnaire 
could be validated among premenopausal women to improve assessment of coffee 
drinks/cocoa for future studies wishing to use an FFQ to assess the effect of caffeine on 
women’s health. 
Assessing caffeine by self-report is difficult, due to the variability in caffeine 
beverage content (24). Available statistical methods to assess usual intake from the 
24HDR with supplemental demographic and FFQ information (25) do not address the 
heterogeneity of caffeine content in beverages nor the between-woman variation in 
caffeine metabolism. While overall caffeine/beverage intake did not vary over the 
menstrual cycle (25), within-woman caffeine metabolism may change over the menstrual 
cycle (26). To improve caffeine exposure assessment among premenopausal women, 
future studies using a combination of self-reported intake with biomarkers may increase 




In summary, we show that although different measures of caffeine and caffeinated 
beverage intakes are highly correlated and have acceptable relative limits of agreement, 
absolute intakes differ significantly between measurement tools. These results highlight 
the importance of considering potential misclassification of caffeine exposure when 
assessing its effect on premenopausal women’s health. Although we show that 
caffeinated beverage intake does not vary over the menstrual cycle, we did not assess 
differences in caffeine metabolism over the menstrual cycle. Further explorations 
examining the relationship between self-reported measures of caffeine and biomarkers of 
caffeine concentrations are needed. 
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Caffeine is the most widely consumed drug in the world and has been consumed 
through natural sources (primarily coffee and tea) for thousands of years, enjoyed for its 
ability to promote alertness and wakefulness (1, 2). Beverages with added caffeine, 
primarily sodas, are more recent arrivals but have quickly become a staple in many 
American diets (3).In addition to its stimulating effects, caffeine has been shown to 
reduce the risk of type 2 diabetes mellitus and obesity and while moderate consumption 
(≤ 400mg/day) has not been found to be associated with general toxicity, heart disease, 
osteoporosis, cancer or male fertility, reproductive-age women are considered to be ‘at 
risk’ and may require special advice in moderating intake (4-7). Several systematic 
reviews have not found a relationship between caffeine consumption and adverse 
reproductive outcomes (8, 9), but note that several methodological limitations, including 
exposure measurement error, limit the ability to rule out plausible alternative 
explanations (8).     
The specific aims of our study were to 1) determine prospectively if caffeine or 
caffeinated beverages are related to serum concentrations of reproductive hormones and 
incident anovulation; 2) determine prospectively if fructose or fructose-rich beverages 
are related to serum concentrations of reproductive hormones and incident anovulation; 




questionnaire (FFQ) compared to the gold-standard of repeated 24-hour dietary recalls 
(24HDRs) among a healthy population of premenopausal women. Our goals for our study 
were to both help inform guidelines as to safe intakes of caffeinated beverages for women 
of reproductive age and improve methodology in how to best assess caffeine and 
caffeinated beverage exposure. 
Key Findings 
Regarding our first objective, we showed that caffeine intake was significantly 
associated with reproductive hormone levels and that this association varied across 
race/ethnicity groups. Higher caffeine and coffee intake was associated with decreased 
total and free estradiol (E2) concentrations among white women and increased total and 
free E2 concentrations among Asian women. In addition, caffeinated soda consumption 
was positively associated with increases in total and free E2 concentrations among all 
races. Caffeine consumption above the recommended levels was not associated with 
anovulation; however, any green tea consumption was associated with increased odds for 
anovulation. Though we observed differences by race, these results were based on a 
relatively small sample size and should be interpreted with caution.  Additional research 
is needed to determine whether these relationships differ by race and mechanisms that 
might explain the differing effect. 
Regarding our second objective, we showed that women who consumed more 
added sugar than an average American woman (≥ 73.2 grams/day) or above the 66th 
percentile in fructose intake (≥ 41.5 grams/day) had elevated free E2, follicular 
stimulating hormone (FSH) and luteinizing hormone (LH) concentrations compared to 




factors, physical activity, and relevant hormones. No associations were found between 
intakes above the American Heart Association’s recommended limits for added sugar 
intake (≥ 40 grams/day) and reproductive hormone levels across the cycle. Women who 
consumed ≥1 cup/day of sweetened soda had elevated free E2 (β=0.15 [95% CI: 0.06, 
0.24]. Neither artificially sweetened soda intake nor fruit juice intake ≥1 cup/day was 
significantly associated with reproductive hormones. No associations were found 
between added sugars, fructose or beverage intake and anovulation. Even at moderate 
consumption levels, added sugars, total fructose, and sweetened soda were associated 
with elevated E2 concentrations among premenopausal women. Further research into 
whether fructose alone or in conjunction with other components in sweetened soda is 
associated with sex hormones is warranted. 
Regarding our third objective, we demonstrated that caffeine intake reported in 
the 24HDRs was less than the FFQs despite high correlation and moderate agreement. 
Women also reported less caffeinated coffee intake in the 24HDR compared to their daily 
diary. Although caffeine and coffee exposures were highly correlated, absolute intakes 
differed significantly between measurement tools. We showed that while the FFQ may be 
appropriate for ranking caffeine and caffeinated beverage exposure, it may not be 
appropriate if the research aim is to classify exposure based on clinically relevant 
cutpoints. These results highlight the importance of considering potential 
misclassification of caffeine exposure and the need for further validation studies with 
biomarker assessment. 
We additionally demonstrated that the FFQ is reproducible over 2 menstrual 




month intake do not significantly differ from values recorded over the study period.  
Finally, repeated measures analyses of both the 8 24HDRs and daily diaries (captured 
over 2 cycles) indicated that neither caffeine nor caffeinated beverage intake varies 
within women over the course of the menstrual cycle. These results show that caffeine 
and caffeinated beverages are habitually consumed by women of reproductive age and 
methods that address episodically consumed foods are not necessary when evaluating 
caffeine or caffeinated beverage exposure. However, further studies assessing differences 
in caffeine metabolism over the menstrual cycle are still needed. 
Public Health Implications 
Our study revealed that inconsistent results regarding the effect of caffeine and 
caffeinated beverages on reproductive function may be due to in part to the inability of 
the FFQ to capture actual intakes. However, a biomarker validation study is needed to 
confirm these findings. Our study also revealed that moderate consumption of 
caffeine/fructose-rich beverages do not pose a risk for anovulatory infertility but may 
affect other chronic disease risk, such as reproductive cancers, via the small but chronic 
elevation or insufficiency of female reproductive hormones, particularly estrogen. Further 
research understanding both the direct and indirect effects of caffeine, fructose, and 
related beverages on reproductive health and how effects may differ by race and what 
other beverage components may be contributing to observed effects is needed. 
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